News

Why Is Athenex (ATNX) Stock Down 54% Today?

Athenex (NASDAQ: ATNX ) stock is falling on Monday after the company announced an agreement with lenders to pursue an expedited sales process. According to a press release from the company, this agreement has it expecting to complete the process by July 1, 2023.

05/15/2023

Athenex, Inc. Reaches Agreement With Lenders to Pursue Expedited Sales Process

To Best Facilitate, Company Voluntarily Files Chapter 11 Proceedings Company Has Sufficient Resources to Support Athenex Pharma Solutions Operations and Fulfill APD Customer Orders During Process BUFFALO, N.Y., May 14, 2023 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX) (“Athenex” or the “Company”), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that, following an ongoing strategic review, it has reached agreement with its lenders to move forward with an expedited sales process of the Company's assets across its primary businesses: Athenex Pharmaceutical Division (“APD”), Orascovery, and Cell Therapy.

05/14/2023

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Athenex, Inc. (ATNX) a buy, sell, or hold?

Athenex, Inc. (ATNX) can hold. Click on Rating Page for detail.

What is Athenex, Inc.'s stock price?

The price of Athenex, Inc. (ATNX) is 0.2031 and it was updated on 2024-11-12 07:01:35.

Is Athenex, Inc. (ATNX) overvalued or undervalued?

Currently Athenex, Inc. (ATNX) is in undervalued.

News

From:

To:

News
Quantum Leap Healthcare Collaborative Announces Result of Oral Paclitaxel in Combination with a PD-1 and Carboplatin from I-SPY2 TRIAL at ASCO SAN FRANCISCO , May 1, 2023 /PRNewswire/ -- Quantum Leap Healthcare Collaborative (Quantum Leap) and Athenex, Inc. (Nasdaq: ATNX) will present the findings of the I-SPY 2 TRIAL evaluation of Athenex's oral paclitaxel plus encequidar in combination with GSK's dostarlimab in the neoadjuvant setting at this year's American Society of Clinical Oncology (ASCO) conference. Athenex, a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions collaborated with GSK and Quantum Leap in two study arms of the I-SPY 2 TRIAL. Mon, May. 01, 2023
Athenex (ATNX) Upgraded to Buy: Here's Why Athenex (ATNX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Thu, Mar. 23, 2023
Athenex Provides Fourth Quarter and Full Year 2022 Financial Results and Business Update Exploring a range of strategic alternatives Mon, Mar. 20, 2023
Milla Pharmaceuticals Inc. and the Alter Pharma Group Announce Launch of a Generic Version of Magnesium Sulfate in Water for Injection, in Non-PVC, Single-Patient Use Containers by Their Partner Athenex Pharmaceutical Division (APD) MINNETONKA, Minn.--(BUSINESS WIRE)--Milla Pharmaceuticals Inc., a subsidiary of the Alter Pharma Group, announced that its partner, Athenex Pharmaceutical Division (APD), has just started to commercialize its abbreviated new drug application (ANDA) approval from the U.S. Mon, Mar. 20, 2023
Athenex Announces a Reverse Stock Split BUFFALO, N.Y., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that it will effect a 1-for-20 reverse stock split of its issued common stock, effective at 12:01 a.m. Eastern Time on February 15, 2023. Beginning tomorrow, February 15, 2023, the Company's common stock will trade on a split-adjusted basis. Tue, Feb. 14, 2023

Transcripts

Transcipts Data
Athenex, Inc. (ATNX) on Q3 2022 Results - Earnings Call Transcript SA Transcripts Sun, Nov. 06, 2022
Athenex, Inc. (ATNX) on Q2 2022 Results - Earnings Call Transcript SA Transcripts Thu, Jul. 28, 2022
Athenex, Inc. (ATNX) on Q1 2022 Results - Earnings Call Transcript SA Transcripts Tue, May. 10, 2022
Athenex, Inc. (ATNX) on Q4 2021 Results - Earnings Call Transcript SA Transcripts Wed, Mar. 16, 2022
Athenex, Inc. (ATNX) on Q3 2021 Results - Earnings Call Transcript SA Transcripts Sun, Nov. 07, 2021
Athenex, Inc. (ATNX) on Q2 2021 Results - Earnings Call Transcript SA Transcripts Sat, Aug. 07, 2021
Athenex, Inc. (ATNX) on Q1 2021 Results - Earnings Call Transcript SA Transcripts Sat, May. 08, 2021

SEC Filings

SEC Filings
Athenex, Inc. (ATNX) - SC 13D/A SEC Filings 10/18/2023
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 10/02/2023
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 08/17/2023
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 07/18/2023
Athenex, Inc. (ATNX) - 25-NSE SEC Filings 07/10/2023
Athenex, Inc. (ATNX) - NT 10-Q - Quarterly Report SEC Filings 05/23/2023
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 05/22/2023
Athenex, Inc. (ATNX) - 4 SEC Filings 05/08/2023
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 05/03/2023
Athenex, Inc. (ATNX) - 10-K/A - Current report SEC Filings 04/28/2023
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 04/25/2023
Athenex, Inc. (ATNX) - 4 SEC Filings 04/24/2023
Athenex, Inc. (ATNX) - 4 SEC Filings 04/11/2023
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 03/31/2023
Athenex, Inc. (ATNX) - 4 SEC Filings 03/27/2023
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 03/20/2023
Athenex, Inc. (ATNX) - 10-K - Current report SEC Filings 03/20/2023
Athenex, Inc. (ATNX) - 4 SEC Filings 03/13/2023
Athenex, Inc. (ATNX) - 4 SEC Filings 02/27/2023
Athenex, Inc. (ATNX) - SC 13D/A SEC Filings 02/14/2023
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 02/14/2023
Athenex, Inc. (ATNX) - 4 SEC Filings 02/13/2023
Athenex, Inc. (ATNX) - SC 13D SEC Filings 02/02/2023
Athenex, Inc. (ATNX) - 4 SEC Filings 01/31/2023
Athenex, Inc. (ATNX) - 4 SEC Filings 01/17/2023
Athenex, Inc. (ATNX) - 4 SEC Filings 01/03/2023
Athenex, Inc. (ATNX) - 4 SEC Filings 12/20/2022
Athenex, Inc. (ATNX) - S-8 SEC Filings 12/09/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 12/06/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 11/22/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 11/21/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 11/21/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 11/08/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 11/03/2022
Athenex, Inc. (ATNX) - 10-Q - Quarterly Report SEC Filings 11/03/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 10/24/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 10/12/2022
Athenex, Inc. (ATNX) - DEFA14A SEC Filings 10/11/2022
Athenex, Inc. (ATNX) - DEF 14A SEC Filings 10/11/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 10/03/2022
Athenex, Inc. (ATNX) - PRE 14A SEC Filings 09/28/2022
Athenex, Inc. (ATNX) - PRE 14A SEC Filings 09/27/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 09/27/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 09/19/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 09/16/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 09/12/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 08/30/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 08/29/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 08/19/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 08/18/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 08/15/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 08/15/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 08/12/2022
Athenex, Inc. (ATNX) - 424B5 SEC Filings 08/12/2022
Athenex, Inc. (ATNX) - 424B5 SEC Filings 08/10/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 08/01/2022
Athenex, Inc. (ATNX) - 10-Q - Quarterly Report SEC Filings 07/29/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 07/28/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 07/21/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 07/18/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 07/11/2022
Athenex, Inc. (ATNX) - SC 13G SEC Filings 07/08/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 07/05/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 07/01/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 06/29/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 06/24/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 06/21/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 06/14/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 06/06/2022
Athenex, Inc. (ATNX) - EFFECT SEC Filings 05/23/2022
Athenex, Inc. (ATNX) - EFFECT SEC Filings 05/23/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 05/23/2022
Athenex, Inc. (ATNX) - POS EX SEC Filings 05/19/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 05/10/2022
Athenex, Inc. (ATNX) - 10-Q - Quarterly Report SEC Filings 05/10/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 05/06/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 04/29/2022
Athenex, Inc. (ATNX) - DEF 14A SEC Filings 04/28/2022
Athenex, Inc. (ATNX) - PRE 14A SEC Filings 04/18/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 04/15/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 04/11/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 03/29/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 03/29/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 03/28/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 03/24/2022
Athenex, Inc. (ATNX) - POS AM SEC Filings 03/22/2022
Athenex, Inc. (ATNX) - POSASR SEC Filings 03/16/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 03/16/2022
Athenex, Inc. (ATNX) - 10-K - Current report SEC Filings 03/16/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 02/24/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 02/22/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 02/15/2022
Athenex, Inc. (ATNX) - SC 13G/A SEC Filings 02/14/2022
Athenex, Inc. (ATNX) - SC 13G/A SEC Filings 02/03/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 01/21/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 01/12/2022
Athenex, Inc. (ATNX) - 4 SEC Filings 01/10/2022
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 12/28/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 11/22/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 11/18/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 11/17/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 11/16/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 11/15/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 11/12/2021
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 11/04/2021
Athenex, Inc. (ATNX) - 10-Q - Quarterly Report SEC Filings 11/04/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 10/13/2021
Athenex, Inc. (ATNX) - SC 13G/A SEC Filings 10/12/2021
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 10/12/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 09/14/2021
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 09/03/2021
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 08/20/2021
Athenex, Inc. (ATNX) - 424B5 SEC Filings 08/20/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 08/17/2021
Athenex, Inc. (ATNX) - 424B5 SEC Filings 08/16/2021
Athenex, Inc. (ATNX) - EFFECT SEC Filings 08/13/2021
Athenex, Inc. (ATNX) - EFFECT SEC Filings 08/13/2021
Athenex, Inc. (ATNX) - CORRESP SEC Filings 08/10/2021
Athenex, Inc. (ATNX) - S-3/A SEC Filings 08/05/2021
Athenex, Inc. (ATNX) - CORRESP SEC Filings 08/05/2021
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 08/05/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 08/05/2021
Athenex, Inc. (ATNX) - 10-Q - Quarterly Report SEC Filings 08/05/2021
Athenex, Inc. (ATNX) - UPLOAD SEC Filings 07/30/2021
Athenex, Inc. (ATNX) - S-8 SEC Filings 07/27/2021
Athenex, Inc. (ATNX) - S-3 SEC Filings 07/27/2021
Athenex, Inc. (ATNX) - 8-K/A - Current report SEC Filings 07/20/2021
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 06/23/2021
Athenex, Inc. (ATNX) - SC 13G SEC Filings 05/27/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 05/10/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 05/07/2021
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 05/06/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 05/06/2021
Athenex, Inc. (ATNX) - 10-Q - Quarterly Report SEC Filings 05/06/2021
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 05/05/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 05/05/2021
Athenex, Inc. (ATNX) - DEF 14A SEC Filings 04/29/2021
Athenex, Inc. (ATNX) - SC 13G/A SEC Filings 04/12/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 04/07/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 03/22/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 03/19/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 03/17/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 03/08/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 03/04/2021
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 03/01/2021
Athenex, Inc. (ATNX) - 10-K - Current report SEC Filings 03/01/2021
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 02/18/2021
Athenex, Inc. (ATNX) - SC 13G/A SEC Filings 02/16/2021
Athenex, Inc. (ATNX) - SC 13G/A SEC Filings 02/12/2021
Athenex, Inc. (ATNX) - SC 13G/A SEC Filings 01/29/2021
Athenex, Inc. (ATNX) - 4 SEC Filings 12/09/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 12/01/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 11/10/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 11/06/2020
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 11/05/2020
Athenex, Inc. (ATNX) - 10-Q - Quarterly Report SEC Filings 11/05/2020
Athenex, Inc. (ATNX) - SC 13D/A SEC Filings 10/09/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 09/24/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 09/21/2020
Athenex, Inc. (ATNX) - 4/A SEC Filings 09/16/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 09/14/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 09/11/2020
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 09/10/2020
Athenex, Inc. (ATNX) - 424B5 SEC Filings 09/10/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 09/10/2020
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 09/08/2020
Athenex, Inc. (ATNX) - 424B5 SEC Filings 09/08/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 08/31/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 08/21/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 08/20/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 08/12/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 08/07/2020
Athenex, Inc. (ATNX) - S-8 SEC Filings 08/06/2020
Athenex, Inc. (ATNX) - S-3ASR SEC Filings 08/06/2020
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 08/06/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 08/06/2020
Athenex, Inc. (ATNX) - 10-Q - Quarterly Report SEC Filings 08/06/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 06/23/2020
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 06/22/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 06/22/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 06/12/2020
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 06/10/2020
Athenex, Inc. (ATNX) - CT ORDER SEC Filings 05/14/2020
Athenex, Inc. (ATNX) - CT ORDER SEC Filings 05/13/2020
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 05/07/2020
Athenex, Inc. (ATNX) - 10-Q - Quarterly Report SEC Filings 05/07/2020
Athenex, Inc. (ATNX) - DEF 14A SEC Filings 04/15/2020
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 03/30/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 03/27/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 03/26/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 03/23/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 03/20/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 03/19/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 03/18/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 03/17/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 03/16/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 03/13/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 03/12/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 03/11/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 03/10/2020
Athenex, Inc. (ATNX) - 10-K - Current report SEC Filings 03/02/2020
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 02/27/2020
Athenex, Inc. (ATNX) - SC 13G/A SEC Filings 02/14/2020
Athenex, Inc. (ATNX) - SC 13G SEC Filings 02/14/2020
Athenex, Inc. (ATNX) - SC 13G SEC Filings 02/07/2020
Athenex, Inc. (ATNX) - S-3ASR SEC Filings 01/28/2020
Athenex, Inc. (ATNX) - 4 SEC Filings 12/27/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 12/26/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 12/19/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 12/18/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 12/17/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 12/16/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 12/13/2019
Athenex, Inc. (ATNX) - D SEC Filings 12/11/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 12/05/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 11/12/2019
Athenex, Inc. (ATNX) - 10-Q - Quarterly Report SEC Filings 11/12/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 11/07/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 10/23/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 10/22/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 10/21/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 10/18/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 10/17/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 10/16/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 09/30/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 09/25/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 09/23/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 09/18/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 09/16/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 09/09/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 08/23/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 08/16/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 08/15/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 08/09/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 08/07/2019
Athenex, Inc. (ATNX) - 10-Q - Quarterly Report SEC Filings 08/07/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 08/02/2019
Athenex, Inc. (ATNX) - S-3ASR SEC Filings 07/23/2019
Athenex, Inc. (ATNX) - UPLOAD SEC Filings 07/22/2019
Athenex, Inc. (ATNX) - CORRESP SEC Filings 07/02/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 06/27/2019
Athenex, Inc. (ATNX) - UPLOAD SEC Filings 06/26/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 06/20/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 06/19/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 06/18/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 06/17/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 06/13/2019
Athenex, Inc. (ATNX) - SC 13G/A SEC Filings 06/07/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 06/07/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 06/06/2019
Athenex, Inc. (ATNX) - CORRESP SEC Filings 05/31/2019
Athenex, Inc. (ATNX) - UPLOAD SEC Filings 05/17/2019
Athenex, Inc. (ATNX) - D SEC Filings 05/15/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 05/09/2019
Athenex, Inc. (ATNX) - 10-Q - Quarterly Report SEC Filings 05/09/2019
Athenex, Inc. (ATNX) - SC 13G/A SEC Filings 05/08/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 05/08/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 05/06/2019
Athenex, Inc. (ATNX) - DEFA14A SEC Filings 04/25/2019
Athenex, Inc. (ATNX) - DEF 14A SEC Filings 04/25/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 04/25/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 04/17/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 04/09/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 04/02/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 04/02/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 03/29/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 03/28/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 03/27/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 03/26/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 03/25/2019
Athenex, Inc. (ATNX) - CT ORDER SEC Filings 03/22/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 03/21/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 03/21/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 03/20/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 03/19/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 03/18/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 03/15/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 03/14/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 03/12/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 03/11/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 03/11/2019
Athenex, Inc. (ATNX) - 10-K - Current report SEC Filings 03/11/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 03/07/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 03/06/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 03/05/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 03/04/2019
Athenex, Inc. (ATNX) - 4 SEC Filings 03/04/2019
Athenex, Inc. (ATNX) - CT ORDER SEC Filings 02/26/2019
Athenex, Inc. (ATNX) - SC 13G/A SEC Filings 02/14/2019
Athenex, Inc. (ATNX) - SC 13G/A SEC Filings 02/12/2019
Athenex, Inc. (ATNX) - SC 13G SEC Filings 02/08/2019
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 01/03/2019
Athenex, Inc. (ATNX) - CT ORDER SEC Filings 12/20/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 12/20/2018
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 12/17/2018
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 12/04/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 12/03/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 11/19/2018
Athenex, Inc. (ATNX) - SC 13G SEC Filings 11/16/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 11/15/2018
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 11/14/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 11/14/2018
Athenex, Inc. (ATNX) - 10-Q - Quarterly Report SEC Filings 11/14/2018
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 10/22/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 10/15/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 09/27/2018
Athenex, Inc. (ATNX) - S-3ASR SEC Filings 09/24/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 09/11/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 09/07/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 08/30/2018
Athenex, Inc. (ATNX) - CT ORDER SEC Filings 08/29/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 08/28/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 08/27/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 08/24/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 08/23/2018
Athenex, Inc. (ATNX) - 4/A SEC Filings 08/21/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 08/21/2018
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 08/20/2018
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 08/17/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 08/17/2018
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 08/14/2018
Athenex, Inc. (ATNX) - 10-Q - Quarterly Report SEC Filings 08/14/2018
Athenex, Inc. (ATNX) - D SEC Filings 07/17/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 07/16/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 07/12/2018
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 07/02/2018
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 06/15/2018
Athenex, Inc. (ATNX) - SC 13D/A SEC Filings 06/14/2018
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 06/14/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 06/13/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 06/07/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 06/06/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 06/05/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 06/01/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 05/30/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 05/29/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 05/24/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 05/23/2018
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 05/14/2018
Athenex, Inc. (ATNX) - 10-Q - Quarterly Report SEC Filings 05/14/2018
Athenex, Inc. (ATNX) - 4/A SEC Filings 05/07/2018
Athenex, Inc. (ATNX) - DEFA14A SEC Filings 04/30/2018
Athenex, Inc. (ATNX) - DEF 14A SEC Filings 04/30/2018
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 04/30/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 04/30/2018
Athenex, Inc. (ATNX) - SC 13D/A SEC Filings 04/27/2018
Athenex, Inc. (ATNX) - SC 13D SEC Filings 04/27/2018
Athenex, Inc. (ATNX) - 4/A SEC Filings 04/27/2018
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 03/26/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 03/26/2018
Athenex, Inc. (ATNX) - 10-K - Current report SEC Filings 03/26/2018
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 03/16/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 02/09/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 02/06/2018
Athenex, Inc. (ATNX) - EFFECT SEC Filings 01/25/2018
Athenex, Inc. (ATNX) - 424B4 SEC Filings 01/25/2018
Athenex, Inc. (ATNX) - S-1/A SEC Filings 01/22/2018
Athenex, Inc. (ATNX) - S-1 SEC Filings 01/22/2018
Athenex, Inc. (ATNX) - CORRESP SEC Filings 01/22/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 01/22/2018
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 01/18/2018
Athenex, Inc. (ATNX) - 4 SEC Filings 01/18/2018
Athenex, Inc. (ATNX) - UPLOAD SEC Filings 01/17/2018
Athenex, Inc. (ATNX) - CT ORDER SEC Filings 01/12/2018
Athenex, Inc. (ATNX) - DRS SEC Filings 01/05/2018
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 01/05/2018
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 12/29/2017
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 12/15/2017
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 12/01/2017
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 11/09/2017
Athenex, Inc. (ATNX) - 10-Q - Quarterly Report SEC Filings 11/09/2017
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 10/05/2017
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 09/08/2017
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 08/14/2017
Athenex, Inc. (ATNX) - 10-Q - Quarterly Report SEC Filings 08/14/2017
Athenex, Inc. (ATNX) - 4/A SEC Filings 07/28/2017
Athenex, Inc. (ATNX) - SC 13G SEC Filings 07/13/2017
Athenex, Inc. (ATNX) - SC 13G SEC Filings 07/05/2017
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 07/05/2017
Athenex, Inc. (ATNX) - SC 13D SEC Filings 06/29/2017
Athenex, Inc. (ATNX) - S-8 SEC Filings 06/27/2017
Athenex, Inc. (ATNX) - 8-K - Current report SEC Filings 06/22/2017
Athenex, Inc. (ATNX) - 4 SEC Filings 06/21/2017
Athenex, Inc. (ATNX) - 424B4 SEC Filings 06/15/2017
Athenex, Inc. (ATNX) - EFFECT SEC Filings 06/14/2017
Athenex, Inc. (ATNX) - CT ORDER SEC Filings 06/13/2017
Athenex, Inc. (ATNX) - CERTNAS SEC Filings 06/12/2017
Athenex, Inc. (ATNX) - 8-A12B SEC Filings 06/12/2017
Athenex, Inc. (ATNX) - CORRESP SEC Filings 06/09/2017
Athenex, Inc. (ATNX) - S-1/A SEC Filings 06/02/2017
Athenex, Inc. (ATNX) - CORRESP SEC Filings 06/02/2017
Athenex, Inc. (ATNX) - UPLOAD SEC Filings 05/23/2017
Athenex, Inc. (ATNX) - S-1/A SEC Filings 05/18/2017
Athenex, Inc. (ATNX) - S-1 SEC Filings 05/12/2017
Athenex, Inc. (ATNX) - D SEC Filings 05/03/2017
Athenex, Inc. (ATNX) - DRSLTR SEC Filings 05/01/2017
Athenex, Inc. (ATNX) - DRS/A SEC Filings 05/01/2017
Athenex, Inc. (ATNX) - UPLOAD SEC Filings 02/07/2017
Athenex, Inc. (ATNX) - DRSLTR SEC Filings 01/25/2017
Athenex, Inc. (ATNX) - DRS/A SEC Filings 01/25/2017
Athenex, Inc. (ATNX) - UPLOAD SEC Filings 01/17/2017
Athenex, Inc. (ATNX) - DRS SEC Filings 12/16/2016
Athenex, Inc. (ATNX) - D SEC Filings 10/07/2016
Athenex, Inc. (ATNX) - D/A SEC Filings 06/16/2015
Athenex, Inc. (ATNX) - D SEC Filings 06/16/2015
Athenex, Inc. (ATNX) - D SEC Filings 05/20/2015
Athenex, Inc. (ATNX) - D SEC Filings 12/23/2013
Athenex, Inc. (ATNX) - D SEC Filings 08/06/2012
Athenex, Inc. (ATNX) - D SEC Filings 04/25/2011
Athenex, Inc. (ATNX) - D/A SEC Filings 02/03/2010
Athenex, Inc. (ATNX) - D SEC Filings 01/07/2010
Athenex, Inc. (ATNX) - REGDEX/A SEC Filings 11/19/2008
Athenex, Inc. (ATNX) - REGDEX SEC Filings 10/20/2008
Athenex, Inc. (ATNX) - REGDEX SEC Filings 08/11/2008
Athenex, Inc. (ATNX) - REGDEX/A SEC Filings 03/11/2008
Athenex, Inc. (ATNX) - REGDEX SEC Filings 02/20/2008
Athenex, Inc. (ATNX) - REGDEX/A SEC Filings 06/04/2007
Athenex, Inc. (ATNX) - REGDEX/A SEC Filings 04/16/2007
Athenex, Inc. (ATNX) - REGDEX/A SEC Filings 11/20/2006
Athenex, Inc. (ATNX) - REGDEX SEC Filings 01/04/2006
Athenex, Inc. (ATNX) - REGDEX SEC Filings 06/22/2005
Athenex, Inc. (ATNX) - REGDEX SEC Filings 08/13/2004

Press Releases

StockPrice Release
Athenex, inc. reaches agreement with lenders to pursue expedited sales process 05/14/2023
Quantum leap healthcare collaborative announces result of oral paclitaxel in combination with a pd-1 and carboplatin from i-spy2 trial at asco 05/01/2023
Athenex provides fourth quarter and full year 2022 financial results and business update 03/20/2023
Milla pharmaceuticals inc. and the alter pharma group announce launch of a generic version of magnesium sulfate in water for injection, in non-pvc, single-patient use containers by their partner athenex pharmaceutical division (apd) 03/20/2023
Athenex announces a reverse stock split 02/14/2023
Athenex announces quantum leap healthcare collaborative reports positive trial result of i-spy2 trial for oral paclitaxel in combination with pd-1 and carboplatin in neoadjuvant breast cancer 12/20/2022
Athenex exits 503b sterile compounding business 12/16/2022
Athenex announces positive results of special stockholder meeting 11/22/2022
Athenex announces closing of the sale of its china api business 11/21/2022
Athenex announces receipt of positive nasdaq listing determination 11/03/2022
Athenex provides third quarter 2022 financial results and business update 11/03/2022
Athenex to provide corporate and financial update for the third quarter 2022 on november 3, 2022 10/24/2022
Athenex files definitive proxy statement for special stockholder meeting 10/11/2022
Athenex to participate in the h.c. wainwright 24th annual global investment conference 09/06/2022
Athenex, inc. announces pricing of $30 million public offering of common stock and warrants 08/11/2022
Athenex, inc. announces proposed underwritten public offering of common stock and warrants 08/10/2022
Athenex provides second quarter 2022 financial results and business update 07/28/2022
Athenex announces publication of data from phase 3 study comparing oral paclitaxel plus encequidar versus intravenous paclitaxel in patients with metastatic breast cancer in the journal of clinical oncology 07/25/2022
Athenex to provide corporate and financial update for the second quarter 2022 on july 28, 2022 07/21/2022
Athenex announces entry into agreement to sell its china api business to tihe capital (bejing) co., ltd. 07/11/2022
Athenex to participate in truist securities cell therapy symposium 06/23/2022
Athenex announces sale of revenues from u.s. and european royalty and milestone interests in klisyri® (tirbanibulin) to sagard healthcare partners and oaktree 06/22/2022
Athenex appoints darrel p. cohen, md, phd as chief medical officer of cell therapy 06/08/2022
Athenex provides first quarter 2022 financial results and business update 05/10/2022
Athenex, texas children's cancer center, and the center for cell and gene therapy at baylor college of medicine to present phase 1 clinical data for kur-501, an autologous gd2 car-nkt cell therapy for relapsed/refractory high risk neuroblastoma at the asgct 25th annual meeting 05/02/2022
Athenex to provide corporate and financial update for the first quarter 2022 on may 10, 2022 04/29/2022
Athenex presents interim data from phase 1 anchor study of kur-502 (allogeneic cd19 car-nkt cells) in relapsed or refractory lymphoma and leukemia at the 2022 transplantation & cellular (“tandem”) meetings of astct and cibmtr 04/25/2022
Athenex provides fourth quarter and full year 2021 financial results and provides business update 03/16/2022
Correction: athenex to provide corporate and financial update for the fourth quarter and full year 2021, on march 16, 2022 03/14/2022
Athenex announces appointment of chief financial officer 02/22/2022
Athenex announces completion of sale of dunkirk manufacturing facility 02/15/2022
Immunitybio completes acquisition of athenex's interest in dunkirk, new york advanced biotech manufacturing facility 02/15/2022
Athenex to present at the 11th annual svb leerink global healthcare conference 02/09/2022
Athenex announces agreement with immunitybio regarding dunkirk manufacturing facility 01/12/2022
Shareholder alert: robbins llp is investigating athenex, inc. (atnx) for shareholders 12/29/2021
Athenex to host a kol webinar today on car-nkt cell approach to cancer and latest data at the 63rd ash annual meeting 12/13/2021
Athenex announces uk mhra validation of the marketing authorization application for oral paclitaxel and encequidar for review 11/29/2021
Athenex to present at the evercore isi 4th annual healthconx conference 11/18/2021
Athenex announces exclusive license agreement with national cancer institute to utilize t cell receptors targeting mutated p53, kras, and egfr for the development of autologous and allogeneic cell therapies 11/09/2021
Athenex presents interim data from anchor study of kur-502 (allogeneic cd19 car-nkt cells) in relapsed or refractory lymphoma and leukemia at 63rd ash annual meeting and exposition 11/04/2021
Athenex to provide corporate and financial update for the third quarter 2021, on november 4, 2021 10/22/2021
Athenex to provide corporate and financial update for the third quarter 2021, on november 5, 2021 10/21/2021
Athenex and the center for cell and gene therapy announce allowance of our first u.s. patent claims around car-nkt cell therapy 10/18/2021
Athenex provides update from fda type a meeting regarding oral paclitaxel + encequidar in metastatic breast cancer 10/11/2021
Athenex presents data from oral paclitaxel + pembrolizumab phase 1 study at esmo 2021 09/16/2021
Athenex to present at the oppenheimer 2021 fall healthcare life sciences & med tech summit 09/15/2021
Athenex provides second quarter 2021 corporate and financial update 08/05/2021
Athenex announces additional licensing agreements for tirbanibulin 07/26/2021
Athenex to provide corporate and financial update for the second quarter 2021 on august 5, 2021 07/22/2021
Athenex announces european commission approval of klisyri® (tirbanibulin) for the topical treatment of actinic keratosis 07/19/2021
Athenex provides update from fda type a meeting regarding oral paclitaxel plus encequidar for the treatment of metastatic breast cancer 07/06/2021
Shareholder alert: robbins llp is investigating athenex, inc. (atnx) for shareholders 06/07/2021
Athenex presents data on oral docetaxel and oral paclitaxel at asco2021 virtual scientific program 06/04/2021
Athenex announces klisyri® (tirbanibulin) receives positive chmp opinion from the european medicines agency (ema) for the treatment of actinic keratosis of the face or scalp 05/21/2021
Athenex, texas children's cancer center, and the center for cell and gene therapy at baylor college of medicine present new clinical data on gd2 car-nkt cells in neuroblastoma at asgct annual meeting 05/17/2021
Athenex provides first quarter 2021 corporate and financial update 05/06/2021
Athenex to acquire kuur therapeutics to expand cell therapy development with off-the-shelf engineered car-nkt platform 05/04/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 05/03/2021
Deadline today: the schall law firm reminds investors of a class action lawsuit against athenex, inc. and encourages investors with losses in excess of $100,000 to contact the firm 05/03/2021
May 3, 2021 atnx investor deadline: bernstein liebhard llp reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit against athenex, inc. 05/03/2021
Atnx final deadline tomorrow: rosen, a longstanding law firm, encourages athenex, inc. investors with losses over $100k to secure counsel before important monday deadline in securities class action - atnx 05/02/2021
Shareholder alert: the gross law firm notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 04/30/2021
Atnx lawsuit: the law offices of vincent wong notify investors of a class action lawsuit involving athenex, inc. 04/30/2021
Atnx alert: the klein law firm announces a lead plaintiff deadline of may 3, 2021 in the class action filed on behalf of athenex, inc. limited shareholders 04/30/2021
Deadline monday alert: the schall law firm reminds investors of a class action lawsuit against athenex, inc. and encourages investors with losses in excess of $100,000 to contact the firm 04/30/2021
Atnx upcoming deadline: bronstein, gewirtz & grossman, llc reminds athenex, inc. shareholders of class action and lead plaintiff deadline: may 3, 2021 04/30/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 04/29/2021
Hagens berman, national trial attorneys, alerts athenex (atnx) investors to may 3rd securities class action deadline, encourages investors with losses to contact the firm immediately 04/29/2021
Atnx final deadline: rosen, respected investor counsel, encourages athenex, inc. investors with losses to secure counsel before important monday deadline in securities class action - atnx 04/29/2021
Atnx lawsuit: the law offices of vincent wong notify investors of a class action lawsuit involving athenex, inc. 04/29/2021
Monday deadline notice: the schall law firm reminds investors of a class action lawsuit against athenex, inc. and encourages investors with losses in excess of $100,000 to contact the firm 04/29/2021
The law offices of frank r. cruz reminds investors of looming deadline in the class action lawsuit against athenex, inc. (atnx) 04/29/2021
Atnx deadline: bronstein, gewirtz & grossman, llc reminds athenex, inc. shareholders of class action and lead plaintiff deadline: may 3, 2021 04/29/2021
Atnx alert: the klein law firm announces a lead plaintiff deadline of may 3, 2021 in the class action filed on behalf of athenex, inc. limited shareholders 04/29/2021
Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in athenex, inc., of class action lawsuit and upcoming deadline - atnx 04/28/2021
Athenex investor alert: shareholder lawsuit filed 04/28/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 04/28/2021
Bronstein, gewirtz & grossman, llc reminds athenex, inc. (atnx) shareholders of class action and lead plaintiff deadline: may 3, 2021 04/28/2021
Monday deadline reminder: the schall law firm reminds investors of a class action lawsuit against athenex, inc. and encourages investors with losses in excess of $100,000 to contact the firm 04/28/2021
Hagens berman, national trial attorneys, reminds athenex (atnx) investors of may 3rd application deadline in securities class action, investors with losses should contact the firm before deadline 04/27/2021
Athenex to provide corporate and financial update for the first quarter 2021 on may 6, 2021 04/27/2021
Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in athenex, inc., of class action lawsuit and upcoming deadline - atnx 04/26/2021
Atnx alert: the klein law firm announces a lead plaintiff deadline of may 3, 2021 in the class action filed on behalf of athenex, inc. limited shareholders 04/26/2021
Scott+scott attorneys at law llp alerts investors to securities class action against athenex, inc. (atnx) and may 3 deadline 04/26/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 04/26/2021
Rosen, a leading law firm, encourages athenex, inc. investors with losses over $100k to secure counsel before important may 3 deadline in securities class action - atnx 04/24/2021
Rosen, skilled investor counsel, encourages athenex, inc. investors with losses over $100k to secure counsel before important may 3 deadline in securities class action - atnx 04/23/2021
Atnx alert: the klein law firm announces a lead plaintiff deadline of may 3, 2021 in the class action filed on behalf of athenex, inc. limited shareholders 04/23/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 04/22/2021
Athenex investor alert: class action lawsuit filed 04/22/2021
Upcoming deadline notice: the schall law firm reminds investors of a class action lawsuit against athenex, inc. and encourages investors with losses in excess of $100,000 to contact the firm 04/22/2021
Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in athenex, inc., of class action lawsuit and upcoming deadline - atnx 04/21/2021
Atnx alert: the klein law firm announces a lead plaintiff deadline of may 3, 2021 in the class action filed on behalf of athenex, inc. limited shareholders 04/20/2021
Lawsuit filed: block & leviton llp has filed a lawsuit against athenex, inc. for securities fraud; investors who lost money should contact the firm 04/20/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 04/20/2021
Athenex investor alert: shareholder lawsuit filed 04/20/2021
Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in athenex, inc., of class action lawsuit and upcoming deadline - atnx 04/19/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 04/16/2021
Upcoming deadline reminder: the schall law firm reminds investors of a class action lawsuit against athenex, inc. and encourages investors with losses in excess of $100,000 to contact the firm 04/16/2021
Hagens berman, national trial attorneys, encourages athenex (atnx) investors with losses to contact its attorneys, securities class action filed and important deadline established 04/14/2021
Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in athenex, inc., of class action lawsuit and upcoming deadline - atnx 04/13/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 04/12/2021
Rosen, a trusted and leading law firm, encourages athenex, inc. investors to secure counsel before important deadline - atnx 04/12/2021
Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in athenex, inc., of class action lawsuit and upcoming deadline - atnx 04/10/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 04/09/2021
Hagens berman, national trial attorneys, encourages athenex (atnx) investors with losses to contact its attorneys, securities class action filed 04/08/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 04/07/2021
Atnx alert: the klein law firm announces a lead plaintiff deadline of may 3, 2021 in the class action filed on behalf of athenex, inc. limited shareholders 04/06/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 04/06/2021
Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in athenex, inc., of class action lawsuit and upcoming deadline - atnx 04/06/2021
Rosen, global investor counsel, encourages athenex, inc. investors with losses to secure counsel before important may 3 deadline – atnx 04/03/2021
Shareholder action notice: the schall law firm reminds investors of a class action lawsuit against athenex, inc. and encourages investors with losses in excess of $100,000 to contact the firm 04/02/2021
Atnx investor notice: rosen, trusted investor counsel, encourages athenex, inc. investors to secure counsel before important deadline - atnx 04/01/2021
Rosen, a longstanding law firm, encourages athenex, inc. investors to secure counsel before important may 3 deadline - atnx 03/29/2021
Scott+scott attorneys at law llp alerts investors to securities class action against athenex, inc. (atnx) and may 3 deadline 03/29/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 03/26/2021
Hagens berman, national trial attorneys, reminds athenex (atnx) investors of securities fraud lawsuit and important deadlines, encourages investors with losses to contact its attorneys 03/25/2021
The law offices of frank r. cruz announces the filing of a securities class action on behalf of athenex, inc. (atnx) investors 03/25/2021
Shareholder alert: the gross law firm notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 03/24/2021
Athenex investor alert: class action lawsuit filed 03/24/2021
Atnx lawsuit: the law offices of vincent wong notify investors of a class action lawsuit involving athenex, inc. 03/24/2021
Atnx alert: the klein law firm announces a lead plaintiff deadline of may 3, 2021 in the class action filed on behalf of athenex, inc. limited shareholders 03/24/2021
Shareholder alert: robbins llp reminds shareholders that athenex, inc. (atnx) is being sued for misleading shareholders 03/24/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 03/24/2021
Pomerantz law firm announces the filing of a class action against athenex, inc., and certain officers - atnx 03/23/2021
Rosen, recognized investor counsel, encourages athenex, inc. investors to secure counsel before important may 3 deadline - atnx 03/23/2021
Atnx lawsuit: the law offices of vincent wong notify investors of a class action lawsuit involving athenex, inc. 03/23/2021
Atnx alert: the klein law firm announces a lead plaintiff deadline of may 3, 2021 in the class action filed on behalf of athenex, inc. limited shareholders 03/23/2021
Lawsuit filed: block & leviton llp has filed a lawsuit against athenex, inc. for securities fraud; investors who lost money should contact the firm 03/23/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 03/23/2021
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of athenex, inc. - atnx 03/21/2021
Atnx alert: the klein law firm announces a lead plaintiff deadline of may 3, 2021 in the class action filed on behalf of athenex, inc. limited shareholders 03/19/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 03/18/2021
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of athenex, inc. - atnx 03/18/2021
Hagens berman, national trial attorneys, notifies athenex (atnx) investors of securities class action and important deadline, encourages investors with losses to contact its attorneys 03/18/2021
Shareholder action alert: the schall law firm announces the filing of a class action lawsuit against athenex, inc. and encourages investors with losses in excess of $100,000 to contact the firm 03/18/2021
Atnx alert: the klein law firm announces a lead plaintiff deadline of may 3, 2021 in the class action filed on behalf of athenex, inc. limited shareholders 03/17/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 03/17/2021
Investor action notice: the schall law firm announces the filing of a class action lawsuit against athenex, inc. and encourages investors with losses in excess of $100,000 to contact the firm 03/17/2021
Athenex investor alert: class action lawsuit filed 03/16/2021
Investor action reminder: the schall law firm announces the filing of a class action lawsuit against athenex, inc. and encourages investors with losses in excess of $100,000 to contact the firm 03/16/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 03/15/2021
Investor action alert: the schall law firm announces the filing of a class action lawsuit against athenex, inc. and encourages investors with losses in excess of $100,000 to contact the firm 03/15/2021
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of athenex, inc. - atnx 03/14/2021
Hagens berman, national trial attorneys, reminds athenex (atnx) investors of filing of securities fraud lawsuit, encourages investors with losses to contact its attorneys 03/12/2021
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of athenex, inc. - atnx 03/12/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 03/11/2021
Atnx alert: the klein law firm announces a lead plaintiff deadline of may 3, 2021 in the class action filed on behalf of athenex, inc. limited shareholders 03/10/2021
Hagens berman, national trial attorneys, announces filing of securities fraud class action on behalf of athenex (atnx) shareholders, encourages investors with losses to contact its attorneys 03/10/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 03/10/2021
Athenex investor alert: class action lawsuit filed 03/10/2021
Atnx alert: the klein law firm announces a lead plaintiff deadline of may 3, 2021 in the class action filed on behalf of athenex, inc. limited shareholders 03/09/2021
Hagens berman, national trial attorneys, encourages athenex (atnx) investors with losses to contact its attorneys, securities fraud case filed 03/08/2021
Rosen, a leading investor rights law firm, encourages athenex, inc. investors to secure counsel before important deadline – atnx 03/08/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 03/08/2021
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of athenex, inc. - atnx 03/07/2021
Shareholder alert: levi & korsinsky, llp notifies shareholders of athenex, inc. of a class action lawsuit and a lead plaintiff deadline of may 3, 2021 - atnx 03/05/2021
Investor action alert: the schall law firm announces the filing of a class action lawsuit against athenex, inc. and encourages investors with losses in excess of $100,000 to contact the firm 03/05/2021
Scott+scott attorneys at law llp alerts investors to securities class action against athenex, inc. (atnx) and may 3 deadline 03/05/2021
Bronstein, gewirtz & grossman, llc notifies athenex, inc. (atnx) investors of class action and encourages shareholders to contact the firm 03/05/2021
Shareholder action reminder: the schall law firm announces the filing of a class action lawsuit against athenex, inc. and encourages investors with losses in excess of $100,000 to contact the firm 03/03/2021
Athenex investor alert: kaplan fox investigates potential securities fraud at athenex, inc. 03/03/2021
Lawsuit filed: block & leviton llp has filed a lawsuit against athenex, inc. for securities fraud; investors who lost money should contact the firm 03/03/2021
Shareholder alert: labaton sucharow investigates claims on behalf of investors of athenex, inc. (nasdaq: atnx) 03/01/2021
Shareholder alert: athenex, inc. investigated for possible securities laws violations by block & leviton llp; investors should contact the firm 03/01/2021
Athenex provides fourth quarter and full year 2020 corporate and financial update 03/01/2021
Athenex announces u.s. launch of klisyri® and licensing of additional territories for tirbanibulin 02/18/2021
Ceo dr. johnson lau recuperating from covid at home 01/25/2021
Ceo dr. johnson lau contracts covid-19 01/08/2021
Athenex to present at the 39th annual j.p. morgan healthcare conference 01/05/2021
Todd younkin appointed president and ceo of semiconductor research corporation (src) 08/07/2020
Giants of cancer care® 2020 awards ceremony will be held virtually in november 08/06/2020
Resumen: el systemic risk council informa al consejo de estabilidad financiera 08/04/2020
Spirit realty capital prices $450 million of 3.200% senior unsecured notes due 2031 08/03/2020
Three exceptional innovators selected to receive the design automation conference under-40 innovators award 07/08/2020

More Headlines

News
A Short Guide to Making Money With Penny Stocks in 2023 Use these tips for making money with penny stocks The post A Short Guide to Making Money With Penny Stocks in 2023 appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 02/04/2023
Penny Stocks To Buy? 3 Stocks Under $1 To Watch Now Penny stocks under $1 to watch this month. The post Penny Stocks To Buy? 01/05/2023
Best Penny Stocks To Buy? 10 Under $1 To Watch This Week Penny stocks to buy for under $1 but are they worth the risk? The post Best Penny Stocks To Buy? 12/27/2022
Best Penny Stocks To Buy? 6 Under $1 To Watch Now Penny stocks under $1 to watch right now. The post Best Penny Stocks To Buy? 12/23/2022
3 Hot Penny Stocks Under $1 To Watch This Week Penny stocks under $1 to watch this week. The post 3 Hot Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 12/21/2022
3 Tips for Identifying Penny Stocks With High Potential Use these tips for finding penny stocks to buy in 2022 The post 3 Tips for Identifying Penny Stocks With High Potential appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 12/21/2022
Why Is Athenex (ATNX) Stock Up 44% Today? Athenex (NASDAQ: ATNX ) stock is rocketing higher on Tuesday thanks to positive results from a high-risk early-stage breast cancer clinical trial. The Phase 2 study covers the use of the company's oral paclitaxel plus encequidar in combination with a PD-1 inhibitor and carboplatin. 12/20/2022
Athenex Announces Quantum Leap Healthcare Collaborative Reports Positive Trial Result of I-SPY2 Trial for Oral Paclitaxel in Combination with PD-1 and Carboplatin in Neoadjuvant Breast Cancer Oral Paclitaxel combination regimen has graduated in this Phase 2 trial in the triple negative breast cancer subgroup Oral Paclitaxel combination regimen has graduated in this Phase 2 trial in the triple negative breast cancer subgroup 12/20/2022
Athenex Exits 503B Sterile Compounding Business Full-year 2022 product sales guidance maintained at 20-25% growth year-over-year Full-year 2022 product sales guidance maintained at 20-25% growth year-over-year 12/16/2022
Athenex Announces Positive Results of Special Stockholder Meeting BUFFALO, N.Y., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced the results of its special meeting of stockholders (the “Special Meeting”), held as a virtual meeting on November 22, 2022. 11/22/2022
Athenex Announces Closing of the Sale of its China API Business BUFFALO, N.Y., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced the closing of the sale of its equity interests in its China subsidiaries, which primarily represent the Company's ownership of its active pharmaceutical ingredient (API) manufacturing business in China, to Chongqing Comfort Pharmaceutical Inc. (Chongqing Comfort). Chongqing Comfort was assigned the rights and obligations under the Equity Purchase Agreement (Agreement) entered into in July 2022 by TiHe Capital (Beijing) Co. Ltd, pursuant to the terms of the Agreement. 11/21/2022
Athenex, Inc. (ATNX) CEO Johnson Lau on Q3 2022 Results - Earnings Call Transcript Athenex, Inc. (NASDAQ:ATNX ) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET Company Participants Tim McCarthy - MD, Investor Relations Johnson Lau - Chief Executive Officer Dan Lang - President, Athenex Cell Therapy Darrel Cohen - Chief Medical Officer, Cell Therapy Jeff Yordon - Chief Operating Officer Joe Annoni - Chief Financial Officer Conference Call Participants Jon Miller - Evercore Yale Jen - Laidlaw & Co Operator Good day, ladies and gentlemen and welcome to the Athenex Third Quarter 2022 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to Tim McCarthy, Managing Director of Investor Relations at LifeSci Advisors. 11/06/2022
Athenex (ATNX) Reports Q3 Loss, Tops Revenue Estimates Athenex (ATNX) delivered earnings and revenue surprises of 12.50% and 16.42%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock? 11/03/2022
Athenex to Participate in the H.C. Wainwright 24th Annual Global Investment Conference BUFFALO, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that management will present at the H.C. Wainwright 24th Annual Global Investment Conference, taking place September 12-14, 2022, in New York, NY and virtually. Company management will also be available for one-on-one investor meetings during the event. Please find additional details about the presentation below. 09/06/2022
Penny Stocks to Buy Premarket on August 5th? 3 to Watch Here's what you need to know about buying penny stocks on August 5th? The post Penny Stocks to Buy Premarket on August 5th? 08/05/2022
Athenex, Inc. (ATNX) CEO Johnson Lau on Q2 2022 Results - Earnings Call Transcript Athenex, Inc. (NASDAQ:ATNX ) Q2 2022 Earnings Conference Call July 28, 2022 8:00 AM ET Company Participants Caileigh Dougherty - Director, Investor Relations Johnson Lau - Chief Executive Officer Dan Lang - President, Athenex Cell Therapy Darrel Cohen - Chief Medical Officer, Cell Therapy Jeff Yordon - Chief Operating Officer Joe Annoni - Chief Financial Officer Conference Call Participants Faisal Khurshid - SVB Securities Jon Miller - Evercore Matt Kaplan - Ladenburg Thalmann Yale Jen - Laidlaw & Co Operator Good day, ladies and gentlemen and welcome to the Second Quarter 2022 Athenex Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to Caileigh Dougherty, Director of Investor Relations. 07/28/2022
Athenex, Inc.'s (ATNX) CEO Johnson Lau on Q1 2022 Results - Earnings Call Transcript Athenex, Inc. (NASDAQ:ATNX ) Q1 2022 Earnings Conference Call May 10, 2022 8:00 AM ET Company Participants Caileigh Dougherty - Investor Relations Johnson Lau - Chief Executive Officer Daniel Lang - President, Athenex Cell Therapy Jeffrey Yordon - Chief Operating Officer Joe Annoni - Chief Financial Officer Kurt Gunter - Chief Medical Officer, Cell Therapy and Head of Regulatory Affairs Conference Call Participants Kevin DeGeeter - Oppenheimer & Co. Robyn Karnauskas - Truist Securities Jonathan Chang - SVB Leerink Yale Jen - Laidlaw & Company Operator Good day, ladies and gentlemen, and welcome to the First Quarter 2022 Athenex Earnings Conference Call. After the presentation, there will be an opportunity to ask questions. 05/10/2022
Athenex, Texas Children's Cancer Center, and the Center for Cell and Gene Therapy at Baylor College of Medicine to Present Phase 1 Clinical Data for KUR-501, an autologous GD2 CAR-NKT Cell Therapy for Relapsed/Refractory High Risk Neuroblastoma at the ASGCT 25th Annual Meeting BUFFALO, N.Y., May 02, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that the Company will present at the upcoming ASGCT 25th Annual Meeting, taking place May 16-19, 2022, in Washington, D.C. The abstract associated with the presentation is now available on the conference website. 05/02/2022
Athenex, Inc. (ATNX) CEO Johnson Lau on Q4 2021 Results - Earnings Call Transcript Athenex, Inc. (ATNX) CEO Johnson Lau on Q4 2021 Results - Earnings Call Transcript 03/16/2022
Athenex to Present at the 11th Annual SVB Leerink Global Healthcare Conference BUFFALO, N.Y., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that Johnson Lau, CEO and Board Chairman, and Daniel Lang, President, Athenex Cell Therapy, will present at the 11th Annual SVB Leerink Global healthcare Conference on Thursday, February 17, 2022, at 3:00 P.M. ET. 02/09/2022
Athenex To Present Subgroup Analysis Of Oral Paclitaxel-Encequidar Combo Data From Breast Cancer Trial Athenex Inc's (NASDAQ: ATNX) abstract for subgroup analysis of its Phase 3 study of oral paclitaxel and encequidar (Oral Paclitaxel) for metastatic breast cancer has been accepted for poster presentation at the 2021 San Antonio Breast Cancer Symposium. The abstract and poster provide data from a post hoc, subgroup analysis of safety, progression-free survival, and overall survival of patients with elevated liver enzymes. 11/22/2021
Are Options Traders Betting on a Big Move in Athenex (ATNX) Stock? Investors need to pay close attention to Athenex (ATNX) stock based on the movements in the options market lately. 11/19/2021
Athenex to Present at the Evercore ISI 4th Annual HealthCONx Conference BUFFALO, N.Y., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that Johnson Lau, CEO and Board Chairman, and Daniel Lang, Senior Director, Corporate Development will present at the Evercore ISI 4th Annual HealthCONx Conference on Tuesday, November 30, 2021 at 3:55 pm ET. 11/18/2021
Athenex, Inc. (ATNX) CEO Johnson Lau on Q3 2021 Results - Earnings Call Transcript Athenex, Inc. (ATNX) CEO Johnson Lau on Q3 2021 Results - Earnings Call Transcript 11/07/2021
Athenex (ATNX) Reports Q3 Loss, Tops Revenue Estimates Athenex (ATNX) delivered earnings and revenue surprises of 19.51% and 66.48%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock? 11/04/2021
Athenex (ATNX) Sees Hammer Chart Pattern: Time to Buy? Athenex (ATNX) has been struggling lately, but the selling pressure may be coming to an end soon. 11/03/2021
Athenex and the Center for Cell and Gene Therapy Announce Allowance of Our First U.S. Patent Claims Around CAR-NKT Cell Therapy Patent includes a pharmaceutical composition claim comprising a plurality of genetically modified CD62L-positive human NKT cells comprising at least one chimeric antigen receptor (CAR) 10/18/2021
After Plunging 25.6% in 4 Weeks, Here's Why the Trend Might Reverse for Athenex (ATNX) Athenex (ATNX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock. 10/12/2021
Athenex Provides Update from FDA Type A Meeting Regarding Oral Paclitaxel + Encequidar in Metastatic Breast Cancer BUFFALO, N.Y., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that it recently held a Type A meeting with the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for oral paclitaxel and encequidar (Oral Paclitaxel) in metastatic breast cancer (mBC). The purpose of the meeting was to review with the FDA a proposed design for a new clinical trial intended to address the deficiencies raised in the Complete Response Letter received in February 2021 and discuss the potential regulatory path forward for Oral Paclitaxel in mBC in the U.S. 10/11/2021
5 Penny Stocks To Buy According To Insiders In September Insiders are buying shares of these penny stocks this months; are you? The post 5 Penny Stocks To Buy According To Insiders In September appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 09/16/2021
Athenex Shares Are Trading Higher On Positive Oral Paclitaxel Data From Solid Tumor Trial Athenex Inc (NASDAQ: ATNX) announced data presentation from a Phase 1 study evaluating encequidar (Oral Paclitaxel) in combination with Merck Co Inc's (NYSE: MRK) Keytruda (pembrolizumab) in advanced solid malignancies. Paclitaxel is one of the most commonly used chemotherapies. 09/16/2021
Athenex Presents Data from Oral Paclitaxel + Pembrolizumab Phase 1 Study at ESMO 2021 Safety Data Help Establish Part B Dose Expansion and Phase 2 Dose; Data showed encouraging anti-tumor activity (4 PR out of 8 evaluable patients) in NSCLC patients who failed prior PD1/PDL1 therapies Safety Data Help Establish Part B Dose Expansion and Phase 2 Dose; Data showed encouraging anti-tumor activity (4 PR out of 8 evaluable patients) in NSCLC patients who failed prior PD1/PDL1 therapies 09/16/2021
Athenex: Is This Stock A Buy, Sell, Or Hold? It's A Hold. Athenex, Inc. is a biopharmaceutical company developing and commercializing next-generation drugs for treating various cancers. Athenex's pipeline consists of four therapeutic programs, Orascovery (P-glycoprotein pump inhibitor), Src Kinase Inhibition, Cell Therapy, and Arginine Deprivation Therapy. 08/31/2021
Athenex, Inc. (ATNX) CEO Johnson Lau on Q2 2021 Results - Earnings Call Transcript Athenex, Inc. (ATNX) CEO Johnson Lau on Q2 2021 Results - Earnings Call Transcript 08/07/2021
Athenex Provides Second Quarter 2021 Corporate and Financial Update Updated investors on FDA Type A Meeting for oral paclitaxel 08/05/2021
Athenex Announces Additional Licensing Agreements for Tirbanibulin Athenex expands its international commercial partnerships for tirbanibulin in Australia, New Zealand and Canada Athenex expands its international commercial partnerships for tirbanibulin in Australia, New Zealand and Canada 07/26/2021
Athenex to Provide Corporate and Financial Update for the Second Quarter 2021 on August 5, 2021 BUFFALO, N.Y., July 22, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that the Company will provide a corporate and financial update for the second quarter 2021, on Thursday, August 5, 2021, before the market opens. Athenex's management team will host a conference call and live audio webcast at 8:00am Eastern Time. 07/22/2021
Athenex Announces European Commission Approval of Klisyri® (tirbanibulin) for the Topical Treatment of Actinic Keratosis BUFFALO, N.Y., July 19, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced today that its partner, Almirall (Almirall, S.A., BME: ALM), has received approval from the European Commission to market Klisyri® (tirbanibulin), indicated for the topical treatment of actinic keratosis (AK) of the face or scalp in adults. Almirall launched Klisyri in the U.S. in February 2021 and will be launching the product in Europe. 07/19/2021
Athenex Issues Update On Oral Paclitaxel Application In Metastatic Breast Cancer Athenex Inc (NASDAQ: ATNX) held a Type A meeting with the FDA during the second quarter of 2021 to discuss the deficiencies raised in the Complete Response Letter (CRL) regarding application for oral paclitaxel plus encequidar to treat metastatic breast cancer. At the meeting, Athenex provided additional analyses, including overall survival data on patient subgroups, to provide a more comprehensive summary of the risk/benefit assessment. 07/06/2021
Athenex Provides Update from FDA Type A Meeting Regarding Oral Paclitaxel Plus Encequidar for the Treatment of Metastatic Breast Cancer BUFFALO, N.Y., July 06, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that the Company held a Type A meeting with the U.S. Food and Drug Administration (FDA) during the second quarter of 2021 to discuss the deficiencies raised in the Complete Response Letter (CRL) received in February. 07/06/2021
SHAREHOLDER ALERT: Robbins LLP is Investigating Athenex, Inc. (ATNX) for Shareholders SAN DIEGO & BUFFALO, N.Y.--(BUSINESS WIRE)---- $ATNX #ATNX--Shareholder rights law firm Robbins LLP is investigating Athenex, Inc. (NASDAQ: ATNX) to determine whether certain Athenex officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company. Athenex is a global clinical stage biopharmaceutical company dedicated to the discovery, development, and commercialization of next generation drugs for the treatment of cancer. One of the Company's main drug can 06/07/2021
Athenex Presents Data on Oral Docetaxel and Oral Paclitaxel at ASCO2021 Virtual Scientific Program BUFFALO, N.Y., June 04, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced today that the Company presented data from a phase I pharmacokinetic study of oral docetaxel plus encequidar (“oral docetaxel”) and updated data from the phase III study of oral paclitaxel plus encequidar (“oral paclitaxel”) illustrating tumor responses by molecular subtype. The data are being presented in two posters at the American Society for Clinical Oncology 2021 (ASCO2021) Virtual Scientific Program, being held from June 4th to June 8th, 2021. 06/04/2021
Athenex Announces Klisyri® (tirbanibulin) Receives Positive CHMP Opinion from the European Medicines Agency (EMA) for the Treatment of Actinic Keratosis of the Face or Scalp European Commission Decision Anticipated by July 2021 European Commission Decision Anticipated by July 2021 05/21/2021
Athenex, Texas Children's Cancer Center, and the Center for Cell and Gene Therapy at Baylor College of Medicine Present New Clinical Data on GD2 CAR-NKT Cells in Neuroblastoma at ASGCT Annual Meeting BUFFALO, N.Y., May 17, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, led by its Orascovery platform, today announced that investigators from Texas Children's Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine presented new clinical data from the ongoing GINAKIT2 phase 1 study of Athenex's cell therapy candidate KUR-501 targeting GD2 in neuroblastoma at the American Society of Gene & Cell Therapy (ASGCT) 24 th Annual Meeting on Friday, May 14, at 11 am ET. 05/17/2021
Athenex, Inc. (ATNX) CEO Johnson Lau on Q1 2021 Results - Earnings Call Transcript Athenex, Inc. (ATNX) CEO Johnson Lau on Q1 2021 Results - Earnings Call Transcript 05/08/2021
ATNX Stock: 13.19% Decrease (From $4.55 To $3.95) Intraday Explanation The stock price of Athenex Inc (NASDAQ: ATNX) decreased 13.19% (from $4.55 to a day low of $3.95) during intraday trading. This is why it happened. 05/06/2021
Athenex: Q1 Earnings Insights Shares of Athenex (NASDAQ:ATNX) moved higher by 2.2% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 12.50% over the past year to ($0.27), which beat the estimate of ($0.40). 05/06/2021
Why Athenex Stock Skyrocketed Today A blockbuster acquisition could help the biotech "convert cancer into a chronic disease." 05/05/2021
ATNX Stock: From $3.71 To $4.97 (33.96% Increase) Pre-Market Explanation The stock price of Athenex Inc (NASDAQ: ATNX) increased from $3.71 to $4.97 pre-market. This is why it happened. 05/05/2021
Athenex Shares Gain After Acquiring Kuur Therapeutics For $70M Cash, $115M Milestone Payments Athenex Inc (NASDAQ: ATNX) shares have risen during premarket trading in reaction to acquiring Kuur Therapeutics Inc, a portfolio company of IP Group plc, for $70 million upfront. Additionally, Kuur shareholders are eligible to receive up to $115 million of milestone payments. 05/05/2021
Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy Development with Off-the-Shelf Engineered CAR-NKT Platform BUFFALO, N.Y., May 04, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, led by its Orascovery platform, today announced that it has acquired Kuur Therapeutics, Inc., the leading developer of off-the-shelf CAR-NKT cell immunotherapies for the treatment of solid and hematological malignancies. 05/04/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - May 3, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information... 05/03/2021
DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Los Angeles, California--(Newsfile Corp. - May 3, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Athenex, Inc. ("Athenex" or "the Company") (NASDAQ: ATNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 7, 2019 and February 26, 2021, inclusive (the... 05/03/2021
ATNX Final Deadline Tomorrow: Rosen, A Longstanding Law Firm, Encourages Athenex, Inc. Investors with Losses over $100K to Secure Counsel Before Important Monday Deadline in Securities Class Action - ATNX New York, New York--(Newsfile Corp. - May 2, 2021) - WHY:. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"), of the important May 3, 2021 lead plaintiff deadline.SO WHAT: If you purchased Athenex securities during the Class Period you may be entitled to compensation without payment of any out of pocket... 05/02/2021
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - April 30, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Athenex, Inc.. (NASDAQ: ATNX)Shareholders who purchased shares of ATNX during the class period listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/athenex-inc-loss-submission-form/?id=15382&from=5CLASS PERIOD : August 7, 2019 to February... 04/30/2021
ATNX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Athenex, Inc. New York, New York--(Newsfile Corp. - April 30, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Athenex, Inc. (NASDAQ: ATNX) ("Athenex") between August 7, 2019 and February 26, 2021.If you suffered a loss, contact us at the link below. There is no cost or obligation to you.http://www.wongesq.com/pslra-1/athenex-inc-loss-submission-form?prid=15374&wire=5 04/30/2021
ATNX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 3, 2021 in the Class Action Filed on Behalf of Athenex, Inc. Limited Shareholders New York, New York--(Newsfile Corp. - April 30, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Athenex, Inc. (NASDAQ: ATNX) alleging that the Company violated federal securities laws.Class Period: August 7, 2019 and February 26, 2021Lead Plaintiff Deadline: May 3, 2021Learn more about your recoverable losses in ATNX: 04/30/2021
DEADLINE MONDAY ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Los Angeles, California--(Newsfile Corp. - April 30, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Athenex, Inc. ("Athenex" or "the Company") (NASDAQ: ATNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 7, 2019 and February 26, 2021, inclusive (the... 04/30/2021
ATNX Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Athenex, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: May 3, 2021 NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Athenex, Inc. ("Athenex" or "the Company") (NASDAQ: ATNX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Athenex securities between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/atn 04/30/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - April 29, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information... 04/29/2021
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors to May 3rd Securities Class Action Deadline, Encourages Investors with Losses to Contact the Firm Immediately San Francisco, California--(Newsfile Corp. - April 29, 2021) - Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now.Class Period: Aug. 7, 2019 - Feb. 26, 2021Lead Plaintiff Deadline: May 3, 2021Visit: www.hbsslaw.com/investor-fraud/ATNXContact An Attorney Now: ATNX@hbsslaw.com844-916-0895Athenex, Inc. (NASDAQ: ATNX) Securities Class Action: The Complaint alleges that throughout the Class Period, Defendants made false statements and omissions about its flagship drug candidate, an o 04/29/2021
ATNX FINAL DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Athenex, Inc. Investors With Losses to Secure Counsel Before Important Monday Deadline in Securities Class Action - ATNX New York, New York--(Newsfile Corp. - April 29, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"), of the important May 3, 2021 lead plaintiff deadline.SO WHAT: If you purchased Athenex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or... 04/29/2021
ATNX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Athenex, Inc. New York, New York--(Newsfile Corp. - April 29, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Athenex, Inc. (NASDAQ: ATNX) ("Athenex") between August 7, 2019 and February 26, 2021.If you suffered a loss, contact us at the link below. There is no cost or obligation to you.http://www.wongesq.com/pslra-1/athenex-inc-loss-submission-form?prid=15310&wire=5 04/29/2021
MONDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Los Angeles, California--(Newsfile Corp. - April 29, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Athenex, Inc. ("Athenex" or "the Company") (NASDAQ: ATNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 7, 2019 and February 26, 2021, inclusive... 04/29/2021
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athenex, Inc. (ATNX) LOS ANGELES--(BUSINESS WIRE)---- $ATNX #investors--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athenex, Inc. (ATNX) 04/29/2021
ATNX Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Athenex, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: May 3, 2021 New York, New York--(Newsfile Corp. - April 29, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Athenex, Inc. ("Athenex" or "the Company") (NASDAQ: ATNX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Athenex securities between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site:... 04/29/2021
ATNX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 3, 2021 in the Class Action Filed on Behalf of Athenex, Inc. Limited Shareholders New York, New York--(Newsfile Corp. - April 29, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Athenex, Inc. (NASDAQ: ATNX) alleging that the Company violated federal securities laws.Class Period: August 7, 2019 and February 26, 2021Lead Plaintiff Deadline: May 3, 2021Learn more about your recoverable losses in ATNX: 04/29/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Athenex, Inc., of Class Action Lawsuit and Upcoming Deadline - ATNX New York, New York--(Newsfile Corp. - April 28, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Athenex, Inc. ("Athenex" or the "Company") (NASDAQ: ATNX) and certain of its officers. The class action, filed in the United States District Court for the Western District of New York, and docketed under 21-cv-00413, is on behalf of a class consisting of all persons and entities other than Defendants that purchased... 04/28/2021
ATHENEX INVESTOR ALERT: Shareholder Lawsuit Filed Boston, Massachusetts--(Newsfile Corp. - April 28, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Athenex, Inc. (NASDAQ: ATNX). The case is currently in the lead plaintiff stage. Investors who purchased ATNX stock or other securities between August 7, 2019 and February 26, 2021 may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/Athenex to submit their information. Investors may also... 04/28/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - April 28, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information... 04/28/2021
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Athenex (ATNX) Investors of May 3rd Application Deadline in Securities Class Action, Investors with Losses Should Contact the Firm Before Deadline San Francisco, California--(Newsfile Corp. - April 27, 2021) - Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now.Class Period: Aug. 7, 2019 - Feb. 26, 2021Lead Plaintiff Deadline: May 3, 2021Visit: www.hbsslaw.com/investor-fraud/ATNXContact An Attorney Now: ATNX@hbsslaw.com844-916-0895Athenex, Inc. (NASDAQ: ATNX) Securities Class Action: The Complaint alleges that throughout the Class Period, Defendants made false statements and omissions about its flagship drug candidate, an o 04/27/2021
Athenex to Provide Corporate and Financial Update for the First Quarter 2021 on May 6, 2021 BUFFALO, N.Y., April 27, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that the Company will provide a corporate and financial update for the first quarter 2021, on Thursday, May 6, 2021, before the market opens. Athenex's management team will host a conference call and live audio webcast at 8:00 am Eastern Time. 04/27/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Athenex, Inc., of Class Action Lawsuit and Upcoming Deadline - ATNX NEW YORK, April 26, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Athenex, Inc. ("Athenex" or the "Company") (NASDAQ: ATNX) and certain of its officers. The class action, filed in the United States District Court for the Western District of New York, and docketed under 21-cv-00413, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquire Athenex common stock between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"). 04/26/2021
ATNX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 3, 2021 in the Class Action Filed on Behalf of Athenex, Inc. Limited Shareholders New York, New York--(Newsfile Corp. - April 26, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Athenex, Inc. (NASDAQ: ATNX) alleging that the Company violated federal securities laws.Class Period: August 7, 2019 and February 26, 2021Lead Plaintiff Deadline: May 3, 2021Learn more about your recoverable losses in ATNX: 04/26/2021
Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Action Against Athenex, Inc. (ATNX) and May 3 Deadline NEW YORK--(BUSINESS WIRE)-- #ATNX--Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Action Against Athenex, Inc. (ATNX) and May 3 Deadline 04/26/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - April 26, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information... 04/26/2021
Rosen, A Leading Law Firm, Encourages Athenex, Inc. Investors with Losses Over $100K to Secure Counsel Before Important May 3 Deadline in Securities Class Action - ATNX New York, New York--(Newsfile Corp. - April 24, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"), of the important May 3, 2021 lead plaintiff deadline.SO WHAT: If you purchased Athenex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees... 04/24/2021
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Athenex, Inc. Investors With Losses Over $100K to Secure Counsel Before Important May 3 Deadline in Securities Class Action - ATNX NEW YORK, April 23, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"), of the important May 3, 2021 lead plaintiff deadline. SO WHAT: If you purchased Athenex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. 04/23/2021
ATNX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 3, 2021 in the Class Action Filed on Behalf of Athenex, Inc. Limited Shareholders New York, New York--(Newsfile Corp. - April 23, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Athenex, Inc. (NASDAQ: ATNX) alleging that the Company violated federal securities laws.Class Period: August 7, 2019 and February 26, 2021Lead Plaintiff Deadline: May 3, 2021Learn more about your recoverable losses in ATNX: 04/23/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - April 22, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information... 04/22/2021
ATHENEX INVESTOR ALERT: Class Action Lawsuit Filed Boston, Massachusetts--(Newsfile Corp. - April 22, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Athenex, Inc. (NASDAQ: ATNX). The case is currently in the lead plaintiff stage. Investors who purchased ATNX stock or other securities between August 7, 2019 and February 26, 2021 may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/Athenex to submit their information. Investors may also... 04/22/2021
UPCOMING DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Los Angeles, California--(Newsfile Corp. - April 22, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Athenex, Inc. ("Athenex" or "the Company") (NASDAQ: ATNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 7, 2019 and February 26, 2021, inclusive (the... 04/22/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Athenex, Inc., of Class Action Lawsuit and Upcoming Deadline - ATNX New York, New York--(Newsfile Corp. - April 21, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Athenex, Inc. ("Athenex" or the "Company") (NASDAQ: ATNX) and certain of its officers. The class action, filed in the United States District Court for the Western District of New York, and docketed under 21-cv-00413, is on behalf of a class consisting of all persons and entities other than Defendants that purchased... 04/21/2021
ATNX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 3, 2021 in the Class Action Filed on Behalf of Athenex, Inc. Limited Shareholders New York, New York--(Newsfile Corp. - April 20, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Athenex, Inc. (NASDAQ: ATNX) alleging that the Company violated federal securities laws.Class Period: August 7, 2019 and February 26, 2021Lead Plaintiff Deadline: May 3, 2021Learn more about your recoverable losses in ATNX: 04/20/2021
LAWSUIT FILED: Block & Leviton LLP Has Filed a Lawsuit Against Athenex, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm Boston, Massachusetts--(Newsfile Corp. - April 20, 2021) - Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, reminds investors that it has filed a class action lawsuit on behalf of shareholders against Athenex, Inc. (NASDAQ: ATNX) and certain of its executives for securities fraud. Investors who purchased Athenex shares between August 7, 2019 and February 26, 2021, and who lost money are strongly encouraged to contact Block & Leviton attorneys at (617) 398-5600,... 04/20/2021
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors to May 3rd Deadline in Securities Class Action, Encourages Investors with Losses to Contact Its Attorneys San Francisco, California--(Newsfile Corp. - April 20, 2021) - Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. Class Period: Aug. 7, 2019 - Feb. 26, 2021Lead Plaintiff Deadline: May 3, 2021Visit: www.hbsslaw.com/investor-fraud/ATNXContact An Attorney Now: ATNX@hbsslaw.com844-916-0895Athenex, Inc. (NASDAQ: ATNX) Securities Class Action: The Complaint alleges that throughout the Class Period, Defendants made false statements and omissions about its flagship drug candidate, a 04/20/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - April 20, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information... 04/20/2021
ATHENEX INVESTOR ALERT: Shareholder Lawsuit Filed Boston, Massachusetts--(Newsfile Corp. - April 20, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Athenex, Inc. (NASDAQ: ATNX). The case is currently in the lead plaintiff stage. Investors who purchased ATNX stock or other securities between August 7, 2019 and February 26, 2021 may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/Athenex to submit their information. Investors may also... 04/20/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Athenex, Inc., of Class Action Lawsuit and Upcoming Deadline - ATNX NEW YORK, April 19, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Athenex, Inc. ("Athenex" or the "Company") (NASDAQ: ATNX) and certain of its officers. The class action, filed in the United States District Court for the Western District of New York, and docketed under 21-cv-00413, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquire Athenex common stock between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"). 04/19/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - April 16, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information... 04/16/2021
UPCOMING DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm LOS ANGELES, April 16, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Athenex, Inc. ("Athenex" or "the Company") (NASDAQ: ATNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 7, 2019 and February 26, 2021, inclusive (the ''Class Period''), are encouraged to contact the firm before May 3, 2021. 04/16/2021
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Athenex (ATNX) Investors with Losses to Contact Its Attorneys, Securities Class Action Filed and Important Deadline Established San Francisco, California--(Newsfile Corp. - April 14, 2021) - Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. Class Period: Aug. 7, 2019 - Feb. 26, 2021Lead Plaintiff Deadline: May 3, 2021Visit: www.hbsslaw.com/investor-fraud/ATNX Contact An Attorney Now: ATNX@hbsslaw.com 844-916-0895Athenex, Inc. (NASDAQ: ATNX) Securities Class Action: The Complaint alleges that throughout the Class Period, Defendants made false statements and omissions... 04/14/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Athenex, Inc., of Class Action Lawsuit and Upcoming Deadline - ATNX NEW YORK, April 13, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Athenex, Inc. ("Athenex" or the "Company") (NASDAQ: ATNX) and certain of its officers. The class action, filed in the United States District Court for the Western District of New York, and docketed under 21-cv-00413, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquire Athenex common stock between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"). 04/13/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - April 12, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information... 04/12/2021
Rosen, A Trusted and Leading Law Firm, Encourages Athenex, Inc. Investors to Secure Counsel Before Important Deadline - ATNX New York, New York--(Newsfile Corp. - April 12, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"), of the important May 3, 2021 lead plaintiff deadline.SO WHAT: If you purchased Athenex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees... 04/12/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Athenex, Inc., of Class Action Lawsuit and Upcoming Deadline - ATNX New York, New York--(Newsfile Corp. - April 10, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Athenex, Inc. ("Athenex" or the "Company") (NASDAQ: ATNX) and certain of its officers. The class action, filed in the United States District Court for the Western District of New York, and docketed under 21-cv-00413, is on behalf of a class consisting of all persons and entities other than Defendants that purchased... 04/10/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - April 9, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information... 04/09/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - April 7, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information... 04/07/2021
ATNX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 3, 2021 in the Class Action Filed on Behalf of Athenex, Inc. Limited Shareholders New York, New York--(Newsfile Corp. - April 6, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Athenex, Inc. (NASDAQ: ATNX) alleging that the Company violated federal securities laws.Class Period: August 7, 2019 and February 26, 2021Lead Plaintiff Deadline: May 3, 2021Learn more about your recoverable losses in ATNX: 04/06/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - April 6, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information... 04/06/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Athenex, Inc., of Class Action Lawsuit and Upcoming Deadline - ATNX NEW YORK, April 6, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Athenex, Inc. ("Athenex" or the "Company") (NASDAQ: ATNX) and certain of its officers. The class action, filed in the United States District Court for the Western District of New York, and docketed under 21-cv-00413, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquire Athenex common stock between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"). 04/06/2021
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Athenex, Inc. Investors With Losses to Secure Counsel Before Important May 3 Deadline – ATNX NEW YORK--(BUSINESS WIRE)-- #ATNX--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the “Class Period”), of the important May 3, 2021 lead plaintiff deadline. SO WHAT: If you purchased Athenex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To 04/03/2021
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm LOS ANGELES, April 2, 2021 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Athenex, Inc. ("Athenex" or "the Company") (NASDAQ: ATNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 7, 2019 and February 26, 2021, inclusive (the ''Class Period''), are encouraged to contact the firm before May 3, 2021. 04/02/2021
ATNX INVESTOR NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Athenex, Inc. Investors to Secure Counsel Before Important Deadline - ATNX NEW YORK, April 1, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"), of the important May 3, 2021 lead plaintiff deadline. SO WHAT: If you purchased Athenex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. 04/01/2021
ROSEN, A LONGSTANDING LAW FIRM, Encourages Athenex, Inc. Investors to Secure Counsel Before Important May 3 Deadline - ATNX New York, New York--(Newsfile Corp. - March 29, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"), of the important May 3, 2021 lead plaintiff deadline.SO WHAT: If you purchased Athenex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees... 03/29/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - March 26, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more... 03/26/2021
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Athenex (ATNX) Investors of Securities Fraud Lawsuit and Important Deadlines, Encourages Investors with Losses to Contact Its Attorneys San Francisco, California--(Newsfile Corp. - March 25, 2021) - Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. Class Period: Aug. 7, 2019 - Feb. 26, 2021Lead Plaintiff Deadline: May 3, 2021Visit: www.hbsslaw.com/investor-fraud/ATNXContact An Attorney Now: ATNX@hbsslaw.com844-916-0895Athenex, Inc. (NASDAQ: ATNX) Securities Class Action: The Complaint alleges that throughout the Class Period, Defendants made false statements and omissions about its flagship drug candidate, an 03/25/2021
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Athenex, Inc. (ATNX) Investors LOS ANGELES, March 25, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Athenex, Inc. ("Athenex" or the "Company") (NASDAQ: ATNX) common stock between August 7, 2019 and February 26, 2021 , inclusive (the "Class Period"). 03/25/2021
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - March 24, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Athenex, Inc..Shareholders who purchased shares of ATNX during the class period listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/athenex-inc-loss-submission-form/?id=14107&from=5CLASS PERIOD : August 7, 2019 to February 26, 2021ALLEGA 03/24/2021
Athenex Investor Alert: Class Action Lawsuit Filed Boston, Massachusetts--(Newsfile Corp. - March 24, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Athenex, Inc. (NASDAQ: ATNX). The case is currently in the lead plaintiff stage. Investors who purchased ATNX stock or other securities between August 7, 2019 and February 26, 2021 may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/Athenex to submit their information. Investors may also... 03/24/2021
ATNX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Athenex, Inc. New York, New York--(Newsfile Corp. - March 24, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021.If you suffered a loss, contact us at the link below. There is no cost or obligation to you. 03/24/2021
ATNX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 3, 2021 in the Class Action Filed on Behalf of Athenex, Inc. Limited Shareholders New York, New York--(Newsfile Corp. - March 24, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Athenex, Inc. (NASDAQ: ATNX) alleging that the Company violated federal securities laws.Class Period: August 7, 2019 and February 26, 2021Lead Plaintiff Deadline: May 3, 2021Learn more about your recoverable losses in ATNX: 03/24/2021
SHAREHOLDER ALERT: Robbins LLP Reminds Shareholders that Athenex, Inc. (ATNX) is Being Sued for Misleading Shareholders SAN DIEGO & BUFFALO, N.Y.--(BUSINESS WIRE)---- $ATNX #ClassAction--Shareholder rights law firm Robbins LLP reminds shareholders that a purchaser of Athenex, Inc. (NASDAQ: ATNX) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between August 7, 2019 and February 26, 2021. Athenex is a global clinical stage biopharmaceutical company dedicated to the discovery, development, and commercialization of next generation drugs for th 03/24/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - March 24, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. (NASDAQ: ATNX) ("Athenex") between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information go to:https://www.zlk.com/pslra-1/athenex-inc-loss-submission-form?prid=14053&wire=5or... 03/24/2021
Pomerantz Law Firm Announces the Filing of a Class Action against Athenex, Inc., and Certain Officers - ATNX NEW YORK, March 23, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Athenex, Inc. ("Athenex" or the "Company") (NASDAQ: ATNX) and certain of its officers. The class action, filed in the United States District Court for the Western District of New York, and docketed under 21-cv-00413, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquire Athenex common stock between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"). 03/23/2021
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Athenex, Inc. Investors to Secure Counsel Before Important May 3 Deadline - ATNX New York, New York--(Newsfile Corp. - March 23, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"), of the important May 3, 2021 lead plaintiff deadline.SO WHAT: If you purchased Athenex securities during the Class Period you may be entitled to compensation without payment of any out of pocket... 03/23/2021
ATNX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Athenex, Inc. New York, New York--(Newsfile Corp. - March 23, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021.If you suffered a loss, contact us at the link below. There is no cost or obligation to you.http://www.wongesq.com/pslra-1/athenex-inc-loss-submission-form?prid=14001&wire=5 03/23/2021
ATNX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 3, 2021 in the Class Action Filed on Behalf of Athenex, Inc. Limited Shareholders New York, New York--(Newsfile Corp. - March 23, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Athenex, Inc. (NASDAQ: ATNX) alleging that the Company violated federal securities laws.Class Period: August 7, 2019 and February 26, 2021Lead Plaintiff Deadline: May 3, 2021Learn more about your recoverable losses in ATNX: 03/23/2021
LAWSUIT FILED: Block & Leviton LLP Has Filed a Lawsuit Against Athenex, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm Boston, Massachusetts--(Newsfile Corp. - March 23, 2021) - Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, reminds investors that it has filed a class action lawsuit on behalf of shareholders against Athenex, Inc. (NASDAQ: ATNX) and certain of its executives for securities fraud. Investors who purchased Athenex shares between August 7, 2019 and February 26, 2021, and who lost money are strongly encouraged to contact Block & Leviton attorneys at (617) 398-5600, via... 03/23/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - March 23, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information... 03/23/2021
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athenex, Inc. (ATNX) LOS ANGELES, March 22, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming May 3, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Athenex, Inc. ("Athenex" or the "Company") (NASDAQ: ATNX) common stock between August 7, 2019 and February 26, 2021 , inclusive (the "Class Period"). If you suffered a loss on your Athenex investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/athenex-inc/. 03/22/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athenex, Inc. - ATNX New York, New York--(Newsfile Corp. - March 21, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Athenex, Inc. (NASDAQ: ATNX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Athenex and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On March... 03/21/2021
ATNX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 3, 2021 in the Class Action Filed on Behalf of Athenex, Inc. Limited Shareholders New York, New York--(Newsfile Corp. - March 19, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Athenex, Inc. (NASDAQ: ATNX) alleging that the Company violated federal securities laws.Class Period: August 7, 2019 and February 26, 2021Lead Plaintiff Deadline: May 3, 2021Learn more about your recoverable losses in ATNX: 03/19/2021
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm LOS ANGELES, March 19, 2021 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athenex, Inc. ("Athenex" or "the Company") (NASDAQ: ATNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 7, 2019 and February 26, 2021, inclusive (the ''Class Period''), are encouraged to contact the firm before May 3, 2021. 03/19/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - March 18, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more... 03/18/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athenex, Inc. - ATNX NEW YORK, March 18, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Athenex, Inc. (NASDAQ: ATNX). Such investors are advised to contact Robert S. 03/18/2021
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Notifies Athenex (ATNX) Investors of Securities Class Action and Important Deadline, Encourages Investors with Losses to Contact Its Attorneys San Francisco, California--(Newsfile Corp. - March 18, 2021) - Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. Class Period: Aug. 7, 2019 - Feb. 26, 2021Lead Plaintiff Deadline: May 3, 2021Visit: www.hbsslaw.com/investor-fraud/ATNX Contact An Attorney Now: ATNX@hbsslaw.com 844-916-0895Athenex, Inc. (NASDAQ: ATNX) Securities Class Action: The Complaint alleges that throughout the Class Period, Defendants made false statements and omissions... 03/18/2021
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Los Angeles, California--(Newsfile Corp. - March 18, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athenex, Inc. ("Athenex" or "the Company") (NASDAQ: ATNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 7, 2019 and February 26, 2021, inclusive... 03/18/2021
ATNX INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Athenex, Inc. NEW YORK, March 18, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Athenex, Inc. ("Athenex" or the "Company") (NASDAQ: ATNX) from August 7, 2019 through February 26, 2021 (the "Class Period"). The lawsuit filed in the United States District Court for the Western District of New York alleges violations of the Securities Exchange Act of 1934. 03/18/2021
ATNX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 3, 2021 in the Class Action Filed on Behalf of Athenex, Inc. Limited Shareholders New York, New York--(Newsfile Corp. - March 17, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Athenex, Inc. (NASDAQ: ATNX) alleging that the Company violated federal securities laws.Class Period: August 7, 2019 and February 26, 2021Lead Plaintiff Deadline: May 3, 2021Learn more about your recoverable losses in ATNX: 03/17/2021
ATNX BREAKING NEWS: ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Athenex, Inc. Investors to Secure Counsel Before Important Deadline - ATNX NEW YORK, March 17, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"), of the important May 3, 2021 lead plaintiff deadline. SO WHAT: If you purchased Athenex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. 03/17/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - March 17, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information... 03/17/2021
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athenex, Inc. (ATNX) BENSALEM, Pa., March 17, 2021 /PRNewswire/ -- Law Offices of Howard G. 03/17/2021
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Los Angeles, California--(Newsfile Corp. - March 17, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athenex, Inc. ("Athenex" or "the Company") (NASDAQ: ATNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 7, 2019 and February 26, 2021, inclusive... 03/17/2021
Athenex Investor Alert: Class Action Lawsuit Filed Boston, Massachusetts--(Newsfile Corp. - March 16, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Athenex, Inc. (NASDAQ: ATNX). The case is currently in the lead plaintiff stage. Investors who purchased ATNX stock or other securities between August 7, 2019 and February 26, 2021 may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/Athenex to submit their information. Investors may also... 03/16/2021
ATNX DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Athenex, Inc. – ATNX NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the “Class Period”). 03/16/2021
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Los Angeles, California--(Newsfile Corp. - March 16, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athenex, Inc. ("Athenex" or "the Company") (NASDAQ: ATNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 7, 2019 and February 26, 2021, inclusive... 03/16/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - March 15, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information... 03/15/2021
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Notifies Athenex (ATNX) Investors of Filing of Securities Fraud Lawsuit, Encourages Investors with Losses to Contact Its Attorneys SAN FRANCISCO, March 15, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. 03/15/2021
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Los Angeles, California--(Newsfile Corp. - March 15, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athenex, Inc. ("Athenex" or "the Company") (NASDAQ: ATNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 7, 2019 and February 26, 2021, inclusive... 03/15/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athenex, Inc. - ATNX New York, New York--(Newsfile Corp. - March 14, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Athenex, Inc. (NASDAQ: ATNX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Athenex and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On March... 03/14/2021
ROSEN, A LEADING LAW FIRM, Encourages Athenex, Inc. Investors with Losses to Secure Counsel Before Important Deadline – ATNX NEW YORK, March 12, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 3, 2021. 03/12/2021
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Athenex (ATNX) Investors of Filing of Securities Fraud Lawsuit, Encourages Investors with Losses to Contact Its Attorneys San Francisco, California--(Newsfile Corp. - March 12, 2021) - Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. Class Period: Aug. 7, 2019 - Feb. 26, 2021Lead Plaintiff Deadline: May 3, 2021Visit: www.hbsslaw.com/investor-fraud/ATNXContact An Attorney Now: ATNX@hbsslaw.com844-916-0895Athenex, Inc. (NASDAQ: ATNX) Securities Class Action: The Complaint alleges that throughout the Class Period, Defendants made false statements and omissions about its flagship drug candidate, an 03/12/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athenex, Inc. - ATNX NEW YORK, March 12, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Athenex, Inc. (NASDAQ: ATNX). Such investors are advised to contact Robert S. 03/12/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - March 11, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information... 03/11/2021
ATNX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 3, 2021 in the Class Action Filed on Behalf of Athenex, Inc. Limited Shareholders New York, New York--(Newsfile Corp. - March 10, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Athenex, Inc. (NASDAQ: ATNX) alleging that the Company violated federal securities laws.Class Period: August 7, 2019 and February 26, 2021Lead Plaintiff Deadline: May 3, 2021Learn more about your recoverable losses in ATNX: 03/10/2021
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Announces Filing of Securities Fraud Class Action on Behalf of Athenex (ATNX) Shareholders, Encourages Investors with Losses to Contact Its Attorneys San Francisco, California--(Newsfile Corp. - March 10, 2021) - Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. Class Period: Aug. 7, 2019 - Feb. 26, 2021Lead Plaintiff Deadline: May 3, 2021Visit: www.hbsslaw.com/investor-fraud/ATNX Contact An Attorney Now: ATNX@hbsslaw.com 844-916-0895Athenex, Inc. (NASDAQ: ATNX) Securities Class Action: The Complaint alleges that throughout the Class Period, Defendants made false statements and omissions... 03/10/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - March 10, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. (NASDAQ: ATNX) ("Athenex") between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more... 03/10/2021
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athenex, Inc. (ATNX) LOS ANGELES--(BUSINESS WIRE)---- $ATNX #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming May 3, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Athenex, Inc. (“Athenex” or the “Company”) (NASDAQ: ATNX) common stock between August 7, 2019 and February 26, 2021, inclusive (the “Class Period”). If you suffered a loss on your Athenex investments or would like to inquire about potentially pursuing claim 03/10/2021
Bronstein, Gewirtz & Grossman, LLC Notifies Athenex, Inc. (ATNX) Investors of Class Action and Encourages Shareholders to Contact the Firm NEW YORK, March 10, 2021 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Athenex, Inc. ("Athenex" or "the Company") (NASDAQ: ATNX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Athenex securities between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/atnx. 03/10/2021
ATHENEX INVESTOR ALERT: Class Action Lawsuit Filed Boston, Massachusetts--(Newsfile Corp. - March 10, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Athenex, Inc. (NASDAQ: ATNX). The case is currently in the lead plaintiff stage. Investors who purchased ATNX stock or other securities between August 7, 2019 and February 26, 2021 may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/Athenex to submit their information. Investors may... 03/10/2021
ATNX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 3, 2021 in the Class Action Filed on Behalf of Athenex, Inc. Limited Shareholders New York, New York--(Newsfile Corp. - March 9, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Athenex, Inc. (NASDAQ: ATNX) alleging that the Company violated federal securities laws.Class Period: August 7, 2019 and February 26, 2021Lead Plaintiff Deadline: May 3, 2021Learn more about your recoverable losses in ATNX: 03/09/2021
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Athenex (ATNX) Investors with Losses to Contact Its Attorneys, Securities Fraud Case Filed SAN FRANCISCO, March 9, 2021 /PRNewswire/ -- Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. Class Period: Aug. 7, 2019 – Feb. 26, 2021 Lead Plaintiff Deadline: May 3, 2021 Visit: www.hbsslaw.com/investor-fraud/ATNX Contact An Attorney Now: ATNX@hbsslaw.com 844-916-0895 Athenex, Inc. (NASDAQ: ATNX) Securities Class Action: The Complaint alleges that throughout the Class Period, Defendants made false statements and omissions about its flagship drug candidate, an oral paclitaxel and encequidar for the treatment of metastatic breast cancer. 03/09/2021
ATNX INVESTOR ALERT: ROSEN, A GLOALLY RECOGNIZED LAW FIRM, Encourages Athenex, Inc. Investors with Losses over $100K to Secure Counsel Before Important Deadline - ATNX New York, New York--(Newsfile Corp. - March 9, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no... 03/09/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - March 9, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. (NASDAQ: ATNX) ("Athenex") between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information... 03/09/2021
Athenex: The CRL Is Devastating Athenex received a CRL from the FDA for its lead asset Oraxol. 03/09/2021
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Athenex (ATNX) Investors with Losses to Contact Its Attorneys, Securities Fraud Case Filed SAN FRANCISCO, March 08, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. 03/08/2021
ATNX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 3, 2021 in the Class Action Filed on Behalf of Athenex, Inc. Limited Shareholders New York, New York--(Newsfile Corp. - March 8, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Athenex, Inc. (NASDAQ: ATNX) alleging that the Company violated federal securities laws.Class Period: August 7, 2019 and February 26, 2021Lead Plaintiff Deadline: May 3, 2021Learn more about your recoverable losses in ATNX: 03/08/2021
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Athenex, Inc. Investors to Secure Counsel Before Important Deadline – ATNX NEW YORK, March 08, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 3, 2021. 03/08/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - March 8, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. (NASDAQ: ATNX) ("Athenex") between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more... 03/08/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athenex, Inc. - ATNX New York, New York--(Newsfile Corp. - March 7, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Athenex, Inc. (NASDAQ: ATNX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Athenex and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On March... 03/07/2021
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Athenex, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - ATNX NEW YORK, March 6, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the "Class... 03/06/2021
SHAREHOLDER ALERT: Robbins LLP Announces That Athenex, Inc. (ATNX) is Being Sued for Misleading Shareholders SAN DIEGO & BUFFALO, N.Y.--(BUSINESS WIRE)---- $ATNX #ClassAction--Shareholder rights law firm Robbins LLP announces that a purchaser of Athenex, Inc. (NASDAQ: ATNX) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between August 7, 2019 and February 26, 2021. Athenex is a global clinical stage biopharmaceutical company dedicated to becoming a leader in the discovery, development, and commercialization of next generation dr 03/05/2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Athenex, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 3, 2021 - ATNX New York, New York--(Newsfile Corp. - March 5, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athenex, Inc. ("Athenex") (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of New York. To get more information... 03/05/2021
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm LOS ANGELES, March 5, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athenex, Inc. ("Athenex" or "the Company") (NASDAQ: ATNX) for violations of §§10(b) and 20(a) of the Securities Exchange... 03/05/2021
Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Action Against Athenex, Inc. (ATNX) and May 3 Deadline NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, announces the filing of a class action lawsuit against Athenex, Inc. (“Athenex” or the “Company”) (NASDAQ: ATNX) and certain of its officers, alleging violations of federal securities laws. If you purchased Athenex common stock between August 7, 2019 and February 26, 2021, inclusive (the “Class Period”), and have suffered a loss, you are encouraged to contact attorney Joe Pettigrew for additional information at (844) 818-6982 or jpettigrew@scott-scott.com . 03/05/2021
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Athenex, Inc. (ATNX) Investors BENSALEM, Pa.--(BUSINESS WIRE)---- $ATNX #CLASSACTION--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Athenex, Inc. (“Athenex” or the “Company”) (NASDAQ: ATNX) securities between August 7, 2019 and February 26, 2021, inclusive (the “Class Period”). Athenex investors have until May 3, 2021 to file a lead plaintiff motion. Investors suffering losses on their Athenex investments are encouraged to contact the Law Offices of Howard G. Smith to discu 03/05/2021
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Athenex, Inc. (ATNX) Investors LOS ANGELES--(BUSINESS WIRE)---- $ATNX #investors--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Athenex, Inc. (ATNX) Investors 03/05/2021
Bronstein, Gewirtz & Grossman, LLC Notifies Athenex, Inc. (ATNX) Investors of Class Action and Encourages Shareholders to Contact the Firm NEW YORK, March 5, 2021 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Athenex, Inc. ("Athenex" or "the Company") (NASDAQ: ATNX) and certain of its officers, on behalf of shareholders who... 03/05/2021
ATNX BREAKING NEWS: ROSEN, A LEADING LAW FIRM, Encourages Athenex, Inc. Investors to Secure Counsel Before Important Deadline – ATNX NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and February 26, 2021, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 3, 2021. SO WHAT: If you purchased Athenex securities during the Class Period you may be 03/04/2021
ATNX INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Athenex, Inc. NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of Athenex, Inc. ("Athenex" or the "Company") (NASDAQ: ATNX) from August 7, 2019 through February 26, 2021 (the “Class Period”). The lawsuit filed in the United States District Court for the Western District of New York alleges violations of the Securities Exchange Act of 1934. 03/04/2021
Notice of Lead Plaintiff Deadline for Shareholders in the Athenex, Inc. Class Action Lawsuit SAN DIEGO--(BUSINESS WIRE)-- #ATNXstock--The suit alleges defendants issued false statements concerning Athenex business and prospects, resulting in its stock trading at inflated prices. 03/04/2021
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Athenex, Inc. (ATNX) on Behalf of Investors LOS ANGELES--(BUSINESS WIRE)---- $ATNX #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Athenex, Inc. (“Athenex” or the “Company”) (NASDAQ: ATNX) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Athenex investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, y 03/04/2021
ATHENEX ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Athenex, Inc. and Encourages Investors to Contact the Firm NEW YORK--(BUSINESS WIRE)-- #Athenex--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Western District of New York on behalf of investors that purchased Athenex, Inc. (NASDAQ: ATNX) common stock between August 7, 2019 and February 26, 2021, inclusive (the “Class Period”). Investors have until May 3, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsui 03/03/2021
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Athenex, Inc. (ATNX) on Behalf of Investors BENSALEM, Pa.--(BUSINESS WIRE)---- $ATNX #CLASSACTION--Law Offices of Howard G. Smith announces an investigation on behalf of Athenex, Inc. (“Athenex” or the “Company”) (NASDAQ: ATNX) investors concerning the Company's possible violations of federal securities laws. Athenex is a clinical stage biopharmaceutical company. Its main product candidate is an oral paclitaxel and encequidar for the treatment of metastatic breast cancer. On September 1, 2020, the Company announced that the U.S. Food and Drug Administration (“ 03/03/2021
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Los Angeles, California--(Newsfile Corp. - March 3, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athenex, Inc. ("Athenex" or "the Company") (NASDAQ: ATNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 7, 2019 and February 26, 2021, inclusive... 03/03/2021
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors to Securities Fraud Investigation and Encourages Investors with Losses to Contact Its Attorneys SAN FRANCISCO, March 03, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims. 03/03/2021
The Law Offices of Frank R. Cruz Announces Investigation of Athenex, Inc. (ATNX) on Behalf of Investors LOS ANGELES--(BUSINESS WIRE)---- $ATNX #investors--The Law Offices of Frank R. Cruz Announces Investigation of Athenex, Inc. (ATNX) on Behalf of Investors 03/03/2021
Athenex Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Athenex, Inc. NEW YORK, March 03, 2021 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.com ) is investigating claims on behalf of investors of Athenex, Inc. (“Athenex” or the “Company”) (NASDAQ: ATNX). 03/03/2021
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm LOS ANGELES--(BUSINESS WIRE)---- $ATNX #ATNX--SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athenex, Inc. 03/03/2021
LAWSUIT FILED: Block & Leviton LLP Has Filed a Lawsuit Against Athenex, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm Boston, Massachusetts--(Newsfile Corp. - March 3, 2021) - Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that it has filed a class action lawsuit on behalf of shareholders against Athenex, Inc. (NASDAQ: ATNX) and certain of its executives for securities fraud. Investors who purchased Athenex shares between August 7, 2019 and February 26, 2021, and who lost money are strongly encouraged to contact Block & Leviton attorneys at (617) 398-5600, via email... 03/03/2021
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Athenex (ATNX) Investors with Losses to Contact Its Attorneys, ATNX Reports FDA Complete Response Letter SAN FRANCISCO, March 2, 2021 /PRNewswire/ -- Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims. Visit:... 03/02/2021
SHAREHOLDER ALERT: Labaton Sucharow Investigates Claims On Behalf of Investors of Athenex, Inc. (NASDAQ: ATNX) NEW YORK--(BUSINESS WIRE)--Labaton Sucharow, a nationally ranked and award-winning shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against Athenex, Inc. (NASDAQ: ATNX). Shares are down over 50% after the Company reported Q4 results and received a complete response letter from the FDA regarding its new drug application for oral paclitaxel plus encequidar for the treatment of metastatic breast cancer. The FDA expressed the following: C 03/02/2021
Athenex, Inc. (ATNX) CEO Johnson Lau on Q4 2020 Results - Earnings Call Transcript Athenex, Inc. (ATNX) CEO Johnson Lau on Q4 2020 Results - Earnings Call Transcript 03/01/2021
Athenex stock plunges to pace all decliners after disappointing FDA response to breast cancer treatment NDA Shares of Athenex Inc. plummeted 54.6% on very active afternoon trading Monday, enough to be the biggest decliner listed on major U.S. exchanges, after the Food and Drug Administration said the biopharmaceutical company's New Drug Application (NDA) for its metastatic breast cancer treatment, oral paclitaxel plus encequidar, is not ready for approval in its present form. Trading volume spiked to 40.1 million shares, compared with the full-day average of about 1.1 million shares. 03/01/2021
Why Morphic, Athenex, Lixte Biotech Are Moving Today Morphic Holding Inc (NASDAQ: MORF), Athenex Inc (NASDAQ: ATNX) and Lixte Biotechnology Holdings Inc (NASDAQ: LIXT) are among the healthcare movers on Monday. Morphic Jumps On Data: Morphic, a biopharma developing oral integrin therapies for treating chronic diseases, reported positive Phase 1 data for its MORF-057, which is being evaluated for inflammatory bowel disease. 03/01/2021
SHAREHOLDER ALERT: Labaton Sucharow Investigates Claims On Behalf of Investors of Athenex, Inc. (NASDAQ: ATNX) NEW YORK--(BUSINESS WIRE)--Labaton Sucharow, a nationally ranked and award-winning shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against Athenex, Inc. (NASDAQ: ATNX). Shares are down over 50% after the Company reported Q4 results and received a complete response letter from the FDA regarding its new drug application for oral paclitaxel plus encequidar for the treatment of metastatic breast cancer. The FDA expressed the following: C 03/01/2021
SHAREHOLDER ALERT: Athenex, Inc. Investigated for Possible Securities Laws Violations by Block & Leviton LLP; Investors Should Contact the Firm Boston, Massachusetts--(Newsfile Corp. - March 1, 2021) - Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that it is investigating Athenex, Inc. (NASDAQ: ATNX) for potential violations of the federal securities laws. Before the markets opened on March 1, 2021, Athenex announced that the U.S. Food and Drug Administration (FDA) had issued a complete response letter (CRL) for the company's New Drug Application for oral paclitaxel plus encequidar for the treatment... 03/01/2021
Athenex (ATNX) Reports Q4 Loss, Tops Revenue Estimates Athenex (ATNX) delivered earnings and revenue surprises of -26.19% and 11.65%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock? 03/01/2021
ATNX Stock Price Fell Over 55% Pre-Market: Why It Happened The stock price of Athenex Inc (NASDAQ: ATNX) fell by over 55% pre-market. This is why it happened. 03/01/2021
Athenex Shares Are Trading Lower After FDA Rejected Oral Paclitaxel Plus Encequidar Application In Breast Cancer The FDA has issued a complete response letter (CRL) for Athenex Inc's (NASDAQ: ATNX) marketing application seeking approval for oral paclitaxel plus encequidar to treat metastatic breast cancer. The CRL indicated concern about an increase in neutropenia-related sequelae observed on the oral paclitaxel arm compared with the IV paclitaxel arm. 03/01/2021
Athenex Provides Fourth Quarter and Full Year 2020 Corporate and Financial Update BUFFALO, N.Y., March 01, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today provided a corporate and financial update for the fourth quarter and full year ended December 31, 2020. 03/01/2021
Athenex's Earnings Outlook Athenex (NASDAQ:ATNX) announces its next round of earnings this Monday, March 01. Here is Benzinga's everything-that-matters guide for this Monday's Q4 earnings announcement. 02/26/2021
Athenex: PDUFA This Week, Depressed Price, Likely Opportunity ATNX won one approval in December and has a PDUFA on Feb 28. 02/24/2021
Athenex to Provide a Corporate and Financial Update for the Fourth Quarter and Full Year 2020 on March 1, 2021 BUFFALO, N.Y., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that the Company will provide a corporate and financial update for the fourth quarter and full year 2020 on Monday, March 1, 2021, before the market opens. Athenex's management team will host a conference call and live audio webcast at 8:00 am Eastern Time. 02/22/2021
Athenex Launches Klisyri In US For Actinic Keratosis; Expands Tirbanibulin Distribution Pact For Additional Territories Athenex Inc (NASDAQ: ATNX) has launched Klisyri (tirbanibulin) in the U.S., led by the Company's partner Almirall. The launch has triggered a milestone payment of up to $65 million. 02/18/2021
Athenex Announces U.S. Launch of Klisyri® and Licensing of Additional Territories for Tirbanibulin BUFFALO, N.Y., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced that today marks the U.S. launch of Klisyri® (tirbanibulin) in the United States, led by the Company's partner Almirall. Athenex announced the licensing of additional territories for tirbanibulin to its partner PharmaEssentia Corp. (Taiwan Exchange: 6446). Athenex received approval from the U.S. Food and Drug Administration (FDA) for Klisyri® for the topical treatment of actinic keratosis of the face or scalp on December 14, 2020. 02/18/2021
CEO Dr. Johnson Lau Recuperating from COVID at Home BUFFALO, N.Y., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced today that its CEO and Board Chairman, Dr. Johnson Lau, has been discharged from the hospital and is doing well recuperating at home. He continues to carry out the full duties and responsibilities of CEO and Chairman of Athenex. 01/25/2021
CEO Dr. Johnson Lau Contracts COVID-19 BUFFALO, N.Y., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced that its CEO and Board Chairman, Dr. Johnson Lau, has contracted COVID-19. Dr. Lau is receiving oral and intravenous treatment at a local hospital, and his condition is currently stable. Dr. Lau is communicating with senior management and continues to serve as Athenex's CEO. Under the advice of his physician, he will not be able to attend the 39th Annual J.P. Morgan Healthcare Conference. Athenex's senior management team will continue to participate and present at the 39th Annual J.P. Morgan Healthcare Conference at its previously scheduled presentation time, and investor one-on-one meetings. 01/08/2021
Athenex to Present at the 39th Annual J.P. Morgan Healthcare Conference BUFFALO, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced that it will participate in the 39th annual J. P. Morgan Healthcare Conference. Johnson Lau, CEO and Board Chairman, and Daniel Lang, Senior Director, Corporate Development, will present a corporate overview at the conference. 01/05/2021
Athenex Presents Updated Phase 3 Data on Survival and Tolerability Associated with Oral Paclitaxel and Encequidar in Patients with Metastatic Breast Cancer BUFFALO, N.Y., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced today the presentation of updated Phase 3 PFS and OS data demonstrating clinical benefits in efficacy and tolerability of oral paclitaxel versus IVP in patients with metastatic breast cancer (MBC). The findings further support the superiority of increased ORR observed with oral paclitaxel. These data were presented today during a spotlight poster presentation at the 2020 San Antonio Breast Cancer Symposium (SABCS). 12/09/2020
Athenex Announces Data on Oral Paclitaxel and Encequidar to be Presented at the 2020 San Antonio Breast Cancer Symposium (SABCS) BUFFALO, N.Y., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced today that oral paclitaxel and encequidar (“oral paclitaxel”) data will be presented in four separate poster presentations at the 2020 San Antonio Breast Cancer Symposium (SABCS) to be held virtually December 8-11. Presentations will include, from the pivotal Phase 3 clinical trial of oral paclitaxel in metastatic breast cancer (MBC), a spotlight poster on progression-free survival (PFS) and overall survival (OS), and posters on neuropathy (CIPN), and management of gastrointestinal (GI) side effects. An additional poster explores oral paclitaxel in the treatment of cutaneous angiosarcoma of the breast. 11/17/2020
Athenex, Inc. Reports Third Quarter Ended September 30, 2020 Financial Results and Provides Corporate Update FDA accepted and granted priority review of NDA for Oral Paclitaxel in metastatic breast cancer 11/05/2020
Investing $5,000 in These 2 Biotechs Could Make You Rich These two companies aren't reinventing the wheel, but they still have the potential for tremendous growth. 10/25/2020
Who Thinks Spirit Is Spooky? (NYSE:SRC) Like many REITs in today's market, Spirit’s shares have struggled in recent months. SRC does have exposure to industries that continue to face major headwinds due to the pandemic. 10/21/2020
Spirit Realty Is A Strong Buy With 100% Upside (NYSE:SRC) Rent collection has jumped above 90% in August. SRC maintains a strong balance sheet rated BBB with room for additional leverage. 10/20/2020
The Edge Court Judgments Report / Part 1 (Part 2 next week) This monthly report is compiled and briefly summarised by a group of lawyers on a voluntary basis for the benefit of readers of The Edge. Please consult your own lawyers if you need advice on the cases, issues and related matters highlighted here. CRIMINAL LAW Corruption, criminal breach of trust and money laundering (‘Offences’) High Court finds former Prime Minister guilty of the offences 10/15/2020
Systemic Risk Council Calls for Renewed Debate on Reforms for Financial System Stability Ahead of a webinar Wednesday, October 14, 2020, the Systemic Risk Council (SRC) today has issued a paper on further possible measures to underpin the resilience and stability of the financial syste… 10/12/2020
Notable Insider Buys of the Past Week: Nikola, Transdigm And More Insider buying can be an encouraging signal for potential investors when markets are near all-time highs. One beneficial owner took advantage of secondary offerings at... 09/20/2020
Athenex Inc (NASDAQ:ATNX) Shares Purchased by American International Group Inc. American International Group Inc. lifted its holdings in Athenex Inc (NASDAQ:ATNX) by 11.4% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 45,024 shares of the company’s stock after purchasing an additional 4,603 shares during the quarter. American International Group Inc. owned about […] 09/17/2020
Goldman Sachs Group Inc. Purchases 125,934 Shares of Athenex Inc (NASDAQ:ATNX) Goldman Sachs Group Inc. increased its position in Athenex Inc (NASDAQ:ATNX) by 23.1% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 671,089 shares of the company’s stock after purchasing an additional 125,934 shares during the quarter. Goldman Sachs Group Inc. owned approximately 0.82% […] 09/15/2020
Athenex Inc (NASDAQ:ATNX) Major Shareholder Perceptive Advisors Llc Acquires 200,000 Shares Athenex Inc (NASDAQ:ATNX) major shareholder Perceptive Advisors Llc bought 200,000 shares of the business’s stock in a transaction on Thursday, September 10th. The shares were acquired at an average price of $11.24 per share, for a total transaction of $2,248,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which […] 09/15/2020
Athenex (ATNX) Investor Presentation - Slideshow The following slide deck was published by Athenex, Inc. in conjunction with this event.. 09/11/2020
Athenex, Inc. Announces Pricing of $110 Million Public Offering of Common Stock 09/10/2020
The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Akouos Inc (NASDAQ: AKUS) Albireo Pharma Inc (NASDAQ: ALB)(announced positive Phase 3 results for odevixibat in a... 09/09/2020
How this automated dairy farm near Kolkata is incorporating environment and animal-friendly practices Founded in 2012, Hooghly-based SRC Farms is setting an example in the dairy industry by taking special care of its cattle’s health, comfort, and nutrition. 08/26/2020
Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Has $1.02 Million Stock Holdings in Spirit Realty Capital Inc (NYSE:SRC) Mitsubishi UFJ Kokusai Asset Management Co. Ltd. raised its holdings in shares of Spirit Realty Capital Inc (NYSE:SRC) by 16.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,381 shares of the real estate investment trust’s stock after purchasing an additional 4,077 […] 08/22/2020
Mall REITs: Shop Till You Drop From bad to worse. Entering 2020 on already unstable footing following a tsunami of store closings over the past half-decade, mall REITs have been punished by the ongoing coronavirus pandemic. 08/18/2020
RADA Electronic Industries Ltd (RADA) CEO Dov Sella on Q2 2020 Results - Earnings Call Transcript RADA Electronic Industries Ltd. (NASDAQ:RADA) Q2 2021 Earnings Conference Call August 11, 2020, 09:00 AM ET Company Participants Ehud Helft - GK Investor Relations Dov Sella - Chief Executive Officer Avi Israel - Chief Financial Officer Conference Call Participants Brian Kinstlinger - Alliance Global Partners Ken Herbert - Canaccord Will Manuel - Edison Group Jeff Bernstein - Cowen Austin Moeller - Canaccord. 08/11/2020
Vereit: Cheapest In Its Peer Group, With Attractive Prospects (NYSE:VER) Vereit is a diversified net lease REIT with retail, restaurant, industrial, and office properties (in that order, by rental revenue). 08/11/2020
Prosecution appealing against Najib's sentences in SRC conviction The prosecution in Datuk Seri Najib Razak's SRC International Sdn Bhd case has filed a notice of appeal against the sentences imposed by the High Court on July 28. Najib was sentenced to 12 years' jail and fined RM210 million after Justice Mohd Nazlan Mohd Ghazali convicted the former premier of all seven charges in relation to the SRC case. 08/11/2020
No Deal, No Problem U.S. equity markets continued their seemingly relentless rally this week despite a stalemate in stimulus negotiations as an encouraging slate of employment data quelled concerns about an ebbing recovery. 08/08/2020
Todd Younkin Appointed President and CEO of Semiconductor Research Corporation (SRC) \| \| IT Business Net Todd Younkin Replaces Ken Hansen who is retiring after leading SRC the past five years. DURHAM, N.C.--(BUSINESS WIRE)--Semiconductor Research Corporation (SRC), a leading global semiconductor research 08/07/2020
Is Athenex, Inc. (NASDAQ:ATNX) Popular Amongst Insiders? If you want to know who really controls Athenex, Inc. (NASDAQ:ATNX), then you'll have to look at the makeup of its... 08/07/2020
Todd Younkin Appointed President and CEO of Semiconductor Research Corporation (SRC) Semiconductor Research Corporation (SRC), a leading global semiconductor research consortium, today announced the appointment of industry veteran Todd 08/07/2020
Athenex (ATNX) Reports Q2 Loss, Tops Revenue Estimates Athenex (ATNX) delivered earnings and revenue surprises of -32.26% and 89.49%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock? 08/06/2020
Very Good News For REIT Investors REITs have been hit hard by the COVID-19 crisis. It led to missed rent payments, defaulting tenants, and dividend cuts. 08/06/2020
Athenex Announces $50 Million Revenue Interest Financing with Sagard Healthcare Royalty Partners Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the 08/06/2020
Sagard Signs $50 Million Royalty Deal for Athenex Cancer Drug Sagard Healthcare Royalty Partners is providing the revenue financing to Athenex and agreed to purchase $50 million of outstanding company loans from Oaktree Capital Management. 08/06/2020
Giants of Cancer Care® 2020 Awards Ceremony Will Be Held Virtually in November Giants of Cancer Care® 2020 Awards Ceremony Will Be Held Virtually in November 08/06/2020
Sumitomo Mitsui Trust Holdings Inc. Grows Position in Spirit Realty Capital Inc (NYSE:SRC) Sumitomo Mitsui Trust Holdings Inc. lifted its holdings in shares of Spirit Realty Capital Inc (NYSE:SRC) by 11.2% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 371,221 shares of the real estate investment trust’s stock after acquiring an additional 37,397 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc.’s holdings in Spirit Realty […] 08/05/2020
Don't Short Blue-Chip REITs (Like Realty Income), You'll Shoot Your Eye Out, Kid (NYSE:O) We all know that Ralphie got the gun he wanted, but Santa was honest about the danger of owning a BB gun. 08/04/2020
Who Paid The Rent? Earnings Halftime Report Did the rent get paid? We just passed the halfway point of another newsworthy REIT earnings season. Results thus far have generally been better than expected with nearly a dozen REITs boosting guidance. 08/04/2020
Biopharmaceutical Leader Robert J. Spiegel, MD, FACP Appointed to the Athenex Board of Directors Pharmaceutical industry veteran with significant oncology clinical development expertise appointed to BoardBUFFALO, N.Y., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced the appointment of Robert J. Spiegel, MD, FACP, a renowned biotech and pharmaceutical executive, to its Board of Directors. “We are thrilled to add an industry executive with Dr. Spiegel’s deep drug development expertise to our Board of Directors,” said Dr. Johnson Lau, Chairman and Chief Executive Officer of Athenex. “Dr. Spiegel is a seasoned leader and has a strong track record of innovation and successful NDA approvals at both large cap pharmas and smaller biotechs. His contribution will be instrumental as we advance our pipeline programs and invest in future label expansion opportunities.”Dr. Spiegel was most recently Chief Medical Officer of PTC Therapeutics and prior to that he was Chief Medical Officer at Schering-Plough. During his tenure of 26 years at Schering, Dr. Spiegel chaired the oncology development team for over 10 years and oversaw over 30 successful New Drug Applications. Dr. Spiegel is an Associate Professor of Medicine at Weill Cornell Medical College. Dr. Spiegel also consults as an Advisor to Warburg Pincus and serves on the Boards of Geron Corporation, Cyclacel Pharmaceuticals, and Ayala Pharmaceuticals.“Athenex has an innovative Orascovery platform that can potentially transform chemotherapies and improve patients' lives. I am excited to join the Athenex Board of Directors and to help the Company further advance their broad clinical pipeline and bring important innovative products to cancer patients,” said Dr. Spiegel. Athenex also announces today that Mr. John Koh has resigned from the company’s Board of Directors. Mr. Koh is stepping down in order to permit the Company to expand the breadth and depth of the pharmaceutical industry expertise of its Board during a critical period of the Company’s growth. The Athenex team and the Board of Directors thanks Mr. Koh for his contribution and commitment to the Company since joining the Board of Directors in April 2019.About Athenex, Inc. Founded in 2003, Athenex, Inc. is a global clinical stage biopharmaceutical company dedicated to becoming a leader in the discovery, development and commercialization of next generation drugs for the treatment of cancer. Athenex is organized around three platforms, including an Oncology Innovation Platform, a Commercial Platform and a Global Supply Chain Platform. The Company’s current clinical pipeline is derived from four different platform technologies: (1) Orascovery, based on P-glycoprotein inhibitor, (2) Src kinase inhibition, (3) T-cell receptor-engineered T-cells (TCR-T), and (4) Arginine deprivation therapy. Athenex’s employees worldwide are dedicated to improving the lives of cancer patients by creating more active and tolerable treatments. Athenex has offices in Buffalo and Clarence, New York; Cranford, New Jersey; Houston, Texas; Chicago, Illinois; Hong Kong; Taipei, Taiwan; multiple locations in Chongqing, China; Manchester, UK; Guatemala City, Guatemala and Buenos Aires, Argentina. For more information, please visit www.athenex.com.CONTACTS Athenex, Inc.: Daniel Lang, MD Corporate Development and Corporate Communications Email: danlang@athenex.comJacqueline Li Corporate Development and Investor Relations Email: jacquelineli@athenex.com 08/04/2020
Appellate court allows withdrawal of Najib's appeal over SRC witness list, statements A three-member Court of Appeal bench today allowed former prime minister Datuk Seri Najib Razak to withdraw his appeal to obtain a list of witnesses interviewed by the Malaysian Anti-Corruption Commission (MACC), as well as their statements, during their investigations into SRC International Sdn Bhd. 08/04/2020
Resumen: El Systemic Risk Council informa al Consejo de Estabilidad Financiera El Systemic Risk Council (SRC) ha emitido hoy sus comentarios al Consejo de Estabilidad Financiera (CEF) en relación con la orientación propuesta por 08/04/2020
Spirit Realty Capital Prices $450 Million of 3.200% Senior Unsecured Notes due 2031 Spirit Realty Capital Prices $450 Million of 3.200% Senior Unsecured Notes due 2031 08/03/2020
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flow continued to pour in,... 08/02/2020
Rent Paid: REITs Rally As Outlook Brightens U.S. equity markets rallied this week as solid corporate earnings results and another slate of stellar housing data contrasted with data showing a record plunge in economic output last quarter. 08/01/2020
Earnings Scheduled For July 31, 2020 Companies Reporting Before The Bell • Chevron Inc. (NYSE:CVX) is expected to report quarterly loss at $0.92 per share on revenue of $22.10 billion. • Weyerhaeuser Inc. (... 07/31/2020
Najib gets 12 years in prison, RM210m fine in SRC verdict First former PM to be sentenced to jail by RAHIMI YUNUS/ pic by ARIF KARTONO FORMER Prime Minister (PM) Datuk Seri Mohd Najib Razak (picture) has been sentenced to 12 years of jail and fined RM210 million for abuse of power involving RM42 million funds misappropriated from SRC International Sdn Bhd. Kuala Lumpur (KL) High […] 07/29/2020
Prosecutor: Najib's appeal process to take a year It would take approximately a year for the appellate court to uphold or throw out Datuk Seri Najib Razak's 12-year jail sentence after he was found guilty of all seven charges at the SRC International Sdn Bhd trial. Speaking to reporters after the former prime minster was sentenced at the High Court, appointed prosecutor Datuk V Sithambaram said that if all goes as planned, it may be a year before Najib will have to face the prospect of serving his sentence. 07/28/2020
SRC Trial: Najib disappointed with judge's decision, determined to appeal Former prime minister Datuk Seri Najib Razak, who has been found guilty of corruption, said he is disappointed by the High Court's decision today and is determined to bring his case to the Court of Appeal as soon as possible. 07/28/2020
Najib's guilty verdict seen to strengthen Muhyiddin's hand Seen as a test of Malaysia's anti-corruption credentials, the guilty verdict against former prime minister Datuk Seri Najib Razak in the first of the 1Malaysia Development Bhd trials could strengthen the new government's hand after months of political turmoil. 07/28/2020
We Are Buying Discounted Net Lease And Mall REITs REITs are very opportunistic and we are taking advantage. Over the past weeks alone, we bought ~$10,000 worth of REITs. 07/28/2020
Zahid: Najib told me this is not the end of the world While Umno accepted the High Court's guilty verdict on former prime minister Datuk Seri Najib Razak's RM42 million SRC International Sdn Bhd trial today, the party will be working on "something", pending discussions on the current government's direction, said its president Datuk Seri Dr Ahmad Zahid Hamidi. 07/28/2020
Judge says no to Najib's bid to delay sentencing mitigation Judge Mohd Nazlan Mohd Ghazali has disallowed an application from former prime minister Datuk Seri Najib Razak to postpone his conviction mitigation to next week. 07/28/2020
Defence applies for a delay in sentence mitigation for Najib until next Monday The defence for former prime minister Datuk Seri Najib Razak, who was found guilty on all seven charges at the SRC International Sdn Bhd trial today, has made an application for mitigation in the case to be put off until next Monday. 07/28/2020
Former Malaysian leader arrives in court for 1MDB corruption verdict Ex-Malaysian Prime Minister Najib Razak arrived at court Tuesday for a verdict in the first of several corruption trials linked to the multibillion-dollar... 07/28/2020
Malaysian ex-PM Najib arrives in court for graft verdict Former Prime Minister Najib Razak has arrived at a Malaysian court for a verdict in his first corruption trial linked to the multibillion-dollar looting of the 1MDB state investment fund 07/28/2020
1MDB scandal: Najib Razak awaits verdict in first trial linked to vast fraud case Former PM has denied criminal breach of trust, money laundering and abuse of power over money transfers 07/28/2020
Malaysian ex-PM Najib in court to face verdict in first 1MDB case Malaysian ex-PM Najib in court to face verdict in first 1MDB case 07/28/2020
Najib: I am ready. Come what may KUALA LUMPUR (July 28): Former Prime Minister Datuk Seri Najib Abdul Razak said that he is ready to face whatever may come at the SRC International Sdn Bhd trial verdict today. Taking to Facebook last night, Najib said whether he is found innocent or guilty by the High Court, it does not stop here. “If I am found not guilty, surely the public prosecutors will appeal the decision at the Federal court. Inversely, if the High court’s decision does not go in my favour, I will bring this case to the court of appeal for a fairer judgment before three judges,” he said. 07/27/2020
Athenex, Inc. to Report Second Quarter 2020 Earnings Results on August 6, 2020 BUFFALO, N.Y., July 27, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that it will release second quarter 2020 financial results on Thursday, August 6, 2020, before the market opens, and host a conference call and live audio webcast 8:00am Eastern Time to discuss the financial results and provide a business update. To participate in the call, dial 877-407-0784 (domestic) or 201-689-8560 (international) fifteen minutes before the conference call begins and reference the conference passcode 13706637. The live conference call and replay can also be accessed via audio webcast at the Investor Relations section of the Company’s website, located at http://ir.athenex.com/.About Athenex, Inc. Founded in 2003, Athenex, Inc. is a global clinical stage biopharmaceutical company dedicated to becoming a leader in the discovery, development and commercialization of next generation drugs for the treatment of cancer. Athenex is organized around three platforms, including an Oncology Innovation Platform, a Commercial Platform and a Global Supply Chain Platform. The Company’s current clinical pipeline is derived from four different platform technologies: (1) Orascovery, based on P-glycoprotein inhibitor, (2) Src kinase inhibition, (3) T-cell receptor-engineered T-cells (TCR-T), and (4) Arginine deprivation therapy. Athenex’s employees worldwide are dedicated to improving the lives of cancer patients by creating more active and tolerable treatments. Athenex has offices in Buffalo and Clarence, New York; Cranford, New Jersey; Houston, Texas; Chicago, Illinois; Hong Kong; Taipei, Taiwan; multiple locations in Chongqing, China; Manchester, UK; Guatemala City, Guatemala and Buenos Aires, Argentina. For more information, please visit www.athenex.com.CONTACTS Athenex, Inc.: Daniel Lang, MD Corporate Development and Corporate Communications Email: danlang@athenex.comJacqueline Li Corporate Development and Investor Relations Email: jacquelineli@athenex.comInvestor Relations: Tim McCarthy Managing Director, LifeSci Advisors, LLC Email: tim@lifesciadvisors.com 07/27/2020
Najib's SRC Trial: Tuesday is D-Day for Najib verdict in SRC case The case of SRC funds totalling RM42 million Total number of charges: 7 3 counts of criminal breach of trustOffence: Section 409 of the Penal CodePenalty: Maximum 20 years’ jail + whipping + a fine 07/27/2020
Najib’s RM27m SRC trial to begin July 5, 2021 by BERNAMA/ pic by BERNAMA THE trial of former prime minister Datuk Seri Najib Tun Razak (picture) on three money-laundering charges involving RM27 million of SRC International Sdn Bhd (SRC) funds will begin on July 5, next year. High Court Judge Mohamed Zaini Mazlan set July 5 to 8; July 12-15 and July 26-29 for the […] 07/27/2020
Saudi Real Estate Refinance to buy mortgage portfolio from pension agency SAUDI Real Estate Refinance Co (SRC), the Saudi equivalent of US mortgage finance business Fannie Mae, said on Sunday that it has agreed to buy a mortgage portfolio worth over 3 billion riyals (S$1.11 billion) from the Saudi Public Pension Agency (PPA). Read more at The Business Times. 07/20/2020
Exelixis Announces Initiation of CONTACT-03 Phase 3 Pivotal Trial of Cabozantinib in Combination With Atezolizumab in Previously Treated Metastatic Renal Cell Carcinoma Exelixis, Inc. (NASDAQ: EXEL) today announced the initiation of CONTACT-03, a global phase 3 pivotal trial of cabozantinib (CABOMETYX®) in combination 07/20/2020
Saudi Real Estate Refinance Co signs 3 billion riyals deal with pension agency Saudi Real Estate Refinance Co (SRC), the Saudi equivalent of U.S. mortgage finance business Fannie Mae, said on Sunday it has agreed to buy a mortgage portfolio worth over 3 billion riyals ($799.8 million) from the Saudi Public Pension Agency (PPA). 07/19/2020
Louisiana State Employees Retirement System Buys 1,600 Shares of Spirit Realty Capital Inc (NYSE:SRC) Louisiana State Employees Retirement System increased its stake in Spirit Realty Capital Inc (NYSE:SRC) by 6.6% during the second quarter, HoldingsChannel reports. The firm owned 25,700 shares of the real estate investment trust’s stock after acquiring an additional 1,600 shares during the period. Louisiana State Employees Retirement System’s holdings in Spirit Realty Capital were worth […] 07/17/2020
Athenex, Inc.'s (NASDAQ:ATNX) Path To Profitability Athenex, Inc.'s (NASDAQ:ATNX): Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and... 07/08/2020
Three Exceptional Innovators Selected to Receive the Design Automation Conference Under-40 Innovators Award Three Exceptional Innovators Selected to Receive the Design Automation Conference Under-40 Innovators Award 07/08/2020
REITs Are Doomed - Not Investors have become very pessimistic on the future prospects of REITs. We saw the same thing happen in 2008-2009. 07/06/2020
No Kanwar yatra in Odisha this year due to coronavirus pandemic Odisha's Special Relief Commissioner (SRC) Pradeep Kumar Jena said that no 'Bol Bom' devotee will be allowed to congregate, carry water from any kind of water body or walk on public roads to pour on lingams in Shiva temples. 07/05/2020
Analysts Expect Spirit Realty Capital Inc (NYSE:SRC) Will Post Quarterly Sales of $114.91 Million Equities research analysts expect Spirit Realty Capital Inc (NYSE:SRC) to post $114.91 million in sales for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Spirit Realty Capital’s earnings, with estimates ranging from $88.95 million to $127.90 million. Spirit Realty Capital posted sales of $106.51 million in the same quarter last […] 07/05/2020
Odisha bans Kanwar yatra due to Covid-19 07/04/2020
Legal & General Group Plc Trims Position in Athenex Inc (NASDAQ:ATNX) Legal & General Group Plc lessened its stake in Athenex Inc (NASDAQ:ATNX) by 10.0% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 28,516 shares of the company’s stock after selling 3,180 shares during the quarter. Legal & General Group Plc’s holdings in Athenex were worth $221,000 at the end of the most recent […] 07/04/2020
Girl power: Young women lead global protests against injustice At this turbulent time, how does South Africa shape up when it comes to activism, and young women activists in particular? 07/02/2020
Mobile coronavirus testing starting for West Haven housing authority residents State Rep. Dorinda Borer said mobile testing only recently became available in the New Haven area. 07/01/2020
DMCI : Resignation of Officers 07/01/2020
Web of corruption? Some of the people implicated in the Petrojam scandal were so strategically placed in positions at the oil refinery that the Integrity Commission is questioning whether they formed part of “corruption-enabling mechanisms”. Academic friendships and... 07/01/2020
Sachs Recreation Center Reopening July 6 The Deerfield Park District is happy to announce that the Sachs fitness center will reopen Monday. 07/01/2020
Odisha issues guidelines for Unlock 2 Odisha announced new guidelines for Unlock 2 keeping in view the central guidelines and the ground situation. The guidelines will be effective from July 1. 06/30/2020
Mandatory masks in shops could create ‘friction and flashpoints’, retailers warn - Evening Telegraph Making face coverings compuslory in Scotland’s shops could create more “frictions and flashpoints” in stores if staff have to enforce rules on wearing them, retail chiefs have warned. 06/30/2020
Mandatory masks in shops could create ‘friction and flashpoints’, retailers warn - Evening Express Making face coverings compuslory in Scotland’s shops could create more “frictions and flashpoints” in stores if staff have to enforce rules on wearing them, retail chiefs have warned. 06/30/2020
University in talks with SRC over 'Kovsies' name outrage The University of the Free State is set to enter into discussions with the Institutional Student Representative Council over the SRC's public outrage at the term 'Kovsies'. 06/29/2020
Weekly CEO Buys Highlight Insiders loaded up on Fox, Magnolia Oil & Gas, Repare Therapeutics, APi Group and Athenex Continue reading... 06/29/2020
Primark sees queues from 4am as shops reopen in Scotland Nicola Sturgeon has urged shoppers to act responsibly and not to “squander” virus progress as more businesses in Scotland reopen. Shops with outdoor entrances were reopening on Monday as part of phase two of lockdown easing, while indoor parts of shopping centres are expected to reopen on July 13. 06/29/2020
Queues form outside shops as Scotland lifts its lockdown restrictions Nicola Sturgeon warns customers not to 'squander' progress on beating coronavirus pandemic 06/29/2020
How non-essential shops in Scotland are opening after lockdown Shops with outdoor entrances will be able to reopen from Monday, while indoor parts of shopping centres are expected to reopen on 13 July 06/29/2020
Hundreds of Scottish shoppers queue for hours to get into Primark Lines of shoppers queued around the block since 6am to get into Scotland's Primarks today after non-essential stores were allowed to be reopened for the first time since coronavirus lockdown 06/29/2020
Nicola Sturgeon urges shoppers not to ‘squander virus progress’ - Evening Telegraph Nicola Sturgeon has urged shoppers to act responsibly and not to “squander” virus progress as more shops reopen. 06/29/2020
Nicola Sturgeon urges shoppers not to ‘squander virus progress’ - Evening Express Nicola Sturgeon has urged shoppers to act responsibly and not to “squander” virus progress as more shops reopen. 06/29/2020
SRC urges UFS to ditch 'racist' Kovsie nickname The students say the name is from an apartheid era when black, Coloured and Indian students were not welcome at the institution. 06/29/2020
SRC turns 60 As the Scientific Research Council (SRC) marks its 60th anniversary this year, the agency’s Executive Director Dr Cliff Riley said the entity is proud of its contribution to national development. “We see this milestone as marking 60 years of... 06/29/2020
Five safety rules shoppers urged to follow as stores reopen today Stores with outdoor entrances will be able to reopen but people are being urged to abide by the five steps for “considerate shopping”. 06/29/2020
Customers urged to follow five rules as shops reopen after lockdown - Evening Express Scottish retailers are urging customers to follow five rules when shops reopen on Monday. 06/28/2020
Customers urged to follow five rules as shops reopen after lockdown - Evening Telegraph Scottish retailers are urging customers to follow five rules when shops reopen on Monday. 06/28/2020
Scotland records no new coronavirus deaths for third day running as shops prepare to re-open Nicola Sturgeon has said she feels "enormous" relief after no new coronavirus deaths were recorded in Scotland for a third day. 06/28/2020
Is Athenex, Inc. (ATNX) A Good Stock To Buy? The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […] 06/28/2020
Race-by-race tips and preview for Scone on Friday They're back in the horse capital for the second time in a week and we've got all you need to find a winner in the upper Hunter. 06/25/2020
Wellington Management Group LLP Lowers Position in Spirit Realty Capital Inc (NYSE:SRC) Wellington Management Group LLP trimmed its holdings in shares of Spirit Realty Capital Inc (NYSE:SRC) by 22.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 201,322 shares of the real estate investment trust’s stock after selling 58,050 shares […] 06/24/2020
Athenex Appoints Teresa Bair, Esq. as Executive Officer and General Counsel Athenex, Inc. (ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced the promotion of Teresa Bair, Esq. Ms. Bair, who has more than 23 years of private and in-house legal experience, advances from the position of Senior Vice President, Legal Affairs and Administration. 06/23/2020
Analysts Offer Insights on Financial Companies: Spirit Realty Capital (NYSE: SRC) and Victory Capital Holdings (NASDAQ: VCTR) - Markets Analysts have been eager to weigh in on the Financial sector with new ratings on Spirit Realty Capital (SRC – 06/23/2020
Visa's 1B Token Milestone — And What Lies Ahead \| PYMNTS.com Visa SVPs said the goal of tokenization – especially in the cloud – and Click to Pay is to move secure consumer credentials beyond Visa cards. 06/23/2020
Athenex 宣佈與 Oaktree 達成 2.25 億美元貸款協議紐約州水牛城, June 23, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc. （下稱「Athenex」或「公司」） (NASDAQ: ATNX) 是一家致力發現、開發和商業化癌症治療及相關疾病新型治療的全球生物製藥公司，於今天宣佈已與領先的全球投資公司 Oaktree... 06/23/2020
Athenex Announces $225 Million Loan Agreement with Oaktree BUFFALO, N.Y., June 22, 2020 -- Athenex, Inc. (“Athenex” or the “Company”) (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and. 06/22/2020
Bitcoin Revolution Scam: Philippines' DOF Warns Of Scheme Using Government Officials' Names The Philippines’ Department of Finance issues a new warning against Bitcoin Revolution, an online investment scam that uses names of Philippine officials to dupe investors into putting money in an unregistered scheme. 06/22/2020
Athenex Inc (NASDAQ:ATNX) Shares Sold by JPMorgan Chase & Co. JPMorgan Chase & Co. reduced its position in shares of Athenex Inc (NASDAQ:ATNX) by 12.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 258,815 shares of the company’s stock after selling 38,084 shares during the period. JPMorgan Chase & […] 06/22/2020
Parametric Portfolio Associates LLC Decreases Stake in Spirit Realty Capital Inc (NYSE:SRC) Parametric Portfolio Associates LLC lowered its position in shares of Spirit Realty Capital Inc (NYSE:SRC) by 32.9% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 211,445 shares of the real estate investment trust’s stock after selling 103,751 shares during the quarter. Parametric Portfolio Associates LLC owned […] 06/21/2020
Quality and high condition are the watchwords for Milestone’s June 27 Premier Antique & Modern Firearms Auction Featured: Two guns factory-engraved by William Gough, including Colt 1911 .45 ACP-caliber gold-inlaid pistol estimated at $25,000-$35,000 06/19/2020
New Fitness Options Available From Sachs Recreation Center "The safety of our members and guests along with our staff is our top priority." 06/18/2020
Retailers welcome ‘significant milestone’ as some shops told they can reopen - Evening Telegraph The Scottish Retail Consortium (SRC) has welcomed the announcement from the First Minister that some shops will be able to reopen this month. 06/18/2020
Retailers welcome ‘significant milestone’ as some shops told they can reopen - Evening Express The Scottish Retail Consortium (SRC) has welcomed the announcement from the First Minister that some shops will be able to reopen this month. 06/18/2020
Najib's SRC Trial: Was Najib a victim or protagonist in the conspiracy? The case of SRC funds totalling RM42 million Total number of charges: 7 3 counts of criminal breach of trust Offence: Section 409 of the Penal Code Penalty: Maximum 20 years’ jail + whipping + a fine 1 count of abuse of power Offence: Section 23(1) of MACC Act 2009 (punishable under Section 24 of the same act) Penalty: Maximum 20 years’ jail + a fine of not less than five times the amount of the bribe, or RM10,000, whichever is higher 06/18/2020
MML Investors Services LLC Increases Stake in Spirit Realty Capital Inc (NYSE:SRC) MML Investors Services LLC increased its position in Spirit Realty Capital Inc (NYSE:SRC) by 8.2% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 16,131 shares of the real estate investment trust’s stock after acquiring an additional 1,224 shares during the quarter. MML Investors Services […] 06/18/2020
Net Lease REITs: 'Social Distancing' Hits Key Tenants Typically viewed as bond-proxies, net lease REITs haven't performed like the safe-haven they were believed to be amid the ongoing coronavirus pandemic, dipping 06/16/2020
Spirit Realty: Risk Reassessed (NYSE:SRC) We recommended a position in Spirit Realty and its preferred shares in April. We analyze how the rent collection trends have developed since then. We explain wh 06/16/2020
June 16, 1976 Foundation pays tribute to moms who provided sanctuary for students June 16 celebrations kicked off on Saturday with a visit to Angie Mbele, one of many Soweto moms who provided sanctuary for student leaders on the run from police during the uprising. 06/15/2020
UKZN warning to ignore calls to return to campus The University of KwaZulu-Natal has warned students against returning to campus after social media posts called for them to return and occupy residences. 06/15/2020
Witness to uprising: What activists remember about 1976 uprising Welma Mashinini Redd, the widow of one of the front line leaders of the uprising Tsietsi Mashinini, says June 16 should be an opportunity to learn from the struggle of the past. 06/14/2020
‘Too early for CPUT nursing students to take up residence’ Third and fourth-year nursing students from the Cape Peninsula University of Technology say the university has denied them a chance to go back to campus. 06/14/2020
Treasurer of the State of North Carolina Buys 17,010 Shares of Spirit Realty Capital Inc (NYSE:SRC) Treasurer of the State of North Carolina grew its stake in Spirit Realty Capital Inc (NYSE:SRC) by 71.1% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 40,930 shares of the real estate investment trust’s stock after purchasing an additional 17,010 shares during the […] 06/14/2020
Pictet Asset Management Ltd. Boosts Position in Spirit Realty Capital Inc (NYSE:SRC) Pictet Asset Management Ltd. increased its stake in Spirit Realty Capital Inc (NYSE:SRC) by 32.5% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 28,033 shares of the real estate investment trust’s stock after acquiring an additional 6,871 shares during the quarter. Pictet Asset Management Ltd.’s holdings in Spirit Realty Capital were worth $733,000 […] 06/14/2020
Athenex Oncology : launches Facing MBC Together campaign to address isolation for people living with metastatic breast cancer \| MarketScreener 06/13/2020
Athenex Oncology launches Facing MBC Together campaign to address isolation for people living with metastatic breast cancer Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer, today announced that Athenex Oncology, a U.S. based division of Athenex, launched Facing MBC Together – a public education and patient support campaign that addresses isolation for people living with metastatic breast cancer (MBC). In addition to providing a unique digital resource that enables the provision of practical and emotional support to individuals with MBC, the campaign, which Athenex Oncology unveiled at the Living Beyond Breast Cancer (LBBC) 2020 Virtual Conference on Metastatic Breast Cancer, highlights the stories of nine people of diverse ages and backgrounds who share their insights about the challenges they face, sources of support, and words of encouragement for others living with this advanced form of breast cancer. 06/13/2020
The Time To Buy REITs Is Right Now A lot of investors claim that it's too late to buy the REIT recovery. In reality, prices remain very attractive even after the recent rally. As we reopen the ec 06/13/2020
Realty Income Vs. W. P. Carey: And The Winner Is... (NYSE:O) Triple-net REITs occupy an exalted place in the REIT-sphere but the pandemic has taken some of their shine. The pandemic also has created opportunities to get i 06/12/2020
Here's what you need to know about phase 2 of Scotland's lockdown, and when the next review is There have been no new deaths from coronavirus in Scotland for the second day in a row 06/12/2020
2 Investments To 'Load Up' Before The Recovery After the recent market rally, investors must become more selective. There still exists some great opportunities among smaller and lesser-known REITs, particula 06/11/2020
Frankly Speaking: A ‘victim’ who received millions After almost 100 days of hearing, defence lawyers for Datuk Seri Najib Razak concluded their submissions before the presiding judge in the SRC trial last Friday by saying that the former prime minister was the victim of a “scam”. Najib’s lawyers pointed the finger at Jho Low as the person behind the “scam” and said their client was ignorant of what was taking place even though millions had gone into his account. 06/11/2020
TUT reprioritises funding to cover for COVID-19 related measures: Nzimande Nzimande made the remarks following his visit to the institution’s campus in Ga-Rankuwa on Tuesday to assess its state of readiness for the phased return of students. 06/10/2020
Principal Financial Group Inc. Has $10.61 Million Stock Holdings in Spirit Realty Capital Inc (NYSE:SRC) Principal Financial Group Inc. decreased its stake in Spirit Realty Capital Inc (NYSE:SRC) by 22.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 405,748 shares of the real estate investment trust’s stock after selling 120,778 shares during the period. […] 06/10/2020
Athenex (NASDAQ:ATNX) Raised to “Buy” at BidaskClub Athenex (NASDAQ:ATNX) was upgraded by research analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, BidAskClub reports. Other equities analysts also recently issued reports about the stock. Oppenheimer initiated coverage on shares of Athenex in a report on Sunday. They set a “buy” rating […] 06/10/2020
Summer Reading Tradition Continues At Emma Clark Library The Summer Reading Club will be exclusively online. 06/09/2020
Here's what you need to know about phase 2 of Scotland's lockdown, and when the next review is There have been no new deaths from coronavirus in Scotland for the second day in a row 06/09/2020
Spirit Realty Capital, Inc. Announces Pricing of Public Offering of 8,000,000 Shares of Common Stock Spirit Realty Capital, Inc. Announces Pricing of Public Offering of 8,000,000 Shares of Common Stock 06/09/2020
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athenex, Inc. - ATNX Pomerantz LLP is investigating claims on behalf of investors of Athenex, Inc. (“Athenex” or the “Company”) (ATNX). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. The investigation concerns whether Athenex and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 06/08/2020
Coronavirus ‘in retreat’ in Scotland as no new deaths recorded for second consecutive day The London Economic \| Sturgeon is now “optimistic” Scotland can move to the second phase of its four-part plan to ease out of lockdown \| News 06/08/2020
Summer Reading Tradition Remains Strong at Emma Clark Library One of your neighbors posted in Community Corner. Click through to read what they have to say. (The views expressed in this post are the author’s own.) 06/07/2020
Shinfield Running Club celebrate members achievements - The Wokingham Paper Shinfield running club has celebrated the graduation of several of its members into their main pool of athletes despite being affected by lockdown measures. 06/07/2020
REITs Surge Amid Reopening Rally U.S. equity markets extended their reopening rally this week amid signs of an emerging V-shaped post-pandemic economic recovery juxtaposed with scenes of violen 06/06/2020
Alteryx: A Post-Pandemic Fortune Maker (NYSE:AYX) Alteryx allows data analysts to perform complex analysis without the need to master a sophisticated coding language. Long-term growth in data generation as well 06/06/2020
Malaysian ex-PM to hear verdict in 1st graft case in July KUALA LUMPUR, Malaysia (AP) - Malaysian ex-Prime Minister Najib Razak was victimized by rogue bankers and should be acquitted of corruption charges linked to the massive looting of a state investment fund, his lawyers said Friday at the close of his first corruption trial over the scandal. The High Court set July 28 to deliver its verdict, which will be closely watched as Najib's Malay political party is reviving its fortunes. The party is part of a new government that took power in March less than two years after it was ousted in 2018 elections amid immense public anger over the 1MDB investment fund scandal. Najib, one of the few Southeast Asian leaders to be arraigned after losing office, faces five criminal cases covering 42 charges of criminal breach of trust, graft, abuse of power and money laundering linked to 1MDB. Najib, 66, faces years in prison if convicted. "We are very confident of a favorable outcome ... we have a good defense," said defense lawyer Mohamad Shafee Abdullah after the hearing ended. Najib, wearing a face mask, left the courthouse without speaking to reporters. The trial began in April 2019 over seven charges related to the transfer of 42 million ringgit ($9.8 million) from a former 1MDB unit into Najib's bank accounts via intermediary companies between 2011 and 2015. Najib is accused of using his position to receive a bribe for approving a government guarantee for billions in loans to the 1MDB unit, SRC International, committing criminal breach of trust and accepting proceeds from unlawful activities. Evidence has shown a complex trail of money through Najib's bank accounts paid for renovating his home, was disbursed to political parties and paid for credit card purchases including a Chanel watch bought in Hawaii as a birthday gift for his wife and luxury jewelry in Italy. In... 06/05/2020
1MDB-linked corruption trial closes, with defence saying Najib was victim of a scam The defence has pinned the blame on elusive financier Low Taek Jho, otherwise known as Jho Low, calling Najib a "victim of a scam".. Read more at straitstimes.com. 06/05/2020
July 28: Decision on Najib’s case for misappropriation of RM42m in SRC fund by BERNAMA/ pic by BERNAMA THE decision whether former prime minister Datuk Seri Najib Tun Razak (picture) will be convicted or acquitted on seven charges of misappropriating RM42 million in SRC International Sdn Bhd’s funds will be known on July 28. High Court judge Mohd Nazlan Mohd Ghazali fixed the date after hearing submissions by both […] 06/05/2020
Malaysia's ex-PM to hear verdict in 1st graft case in July Lawyers for Malaysia’s former Prime Minister Najib Razak say he was victimized by rogue bankers and should be acquitted of corruption linked to the massive looting of a state investment fund 06/05/2020
Malaysia's ex-PM to hear verdict in 1st graft case in July Lawyers for Malaysia’s former Prime Minister Najib Razak say he was victimized by rogue bankers and should be acquitted of corruption linked to the massive looting of a state investment fund 06/05/2020
Malaysian ex-PM Najib faces July verdict in first 1MDB-linked trial Malaysian ex-PM Najib faces July verdict in first 1MDB-linked trial 06/05/2020
Shafee: It's hard to mount a defence for Najib because of prejudice The defence in former prime minister Datuk Seri Najib Razak’s SRC International Sdn Bhd trial told the High Court here today that it was difficult to mount the best defence possible for their client as he was a prime minister and a man with immense power. Lead defence lawyer Tan Sri Muhammad Shafee Abdullah, who was giving his oral submissions during the trial today, said the defence had an uphill task to defend Najib as “a victim of a scam” because of the prejudice that he was a man of finance and, therefore, should have been aware of the money coming into his accounts. 06/04/2020
1MDB-Tanore trial vacated to make way for last leg of SRC, to resume on June 29 The 1MDB-Tanore trial will resume on June 29 as it has been vacated today to make way for the last leg of the SRC International Sdn Bhd trial. As both cases involve former prime minister Datuk Seri Najib Razak as the accused, Najib’s lawyer Tan Sri Muhammad Shafee Abdullah had sought to vacate the 1MDB-Tanore trial for today as the defence is currently in the midst of making their oral submissions in the SRC case. 06/04/2020
SRC trial could reach completion today after more than a year It was exactly a year, two months and a day since Former Prime Minister Datuk Seri Najib Razak began his SRC International Sdn Bhd trial where he faced several charges for Criminal Breach of Trust, Money Laundering and Abuse of power. Today lawyers from the prosecution and defence will possibly rest their respective cases after a long, hard fought trial. 06/03/2020
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athenex, Inc. - ATNX Pomerantz LLP is investigating claims on behalf of investors of Athenex, Inc. (“Athenex” or the “Company”) (ATNX). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. The investigation concerns whether Athenex and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 06/03/2020
Sufficient evidence to show Najib abused power, says prosecutor The court must see from the perspective of decent people whether Najib's evidence is believable, prosecutor says at end of case. 06/03/2020
Prosecution says no need to call SRC CFO to the stand as other witnesses had verified fund transfers The prosecution at the SRC International Sdn Bhd trial explained that they did not need to call SRC’s chief financial officer (CFO) See Yoke Peng as a witness to verify that she had approved the transfer of hundreds of millions of ringgit out of the company as other witnesses had already verified this fact. 06/03/2020
Prosecution in SRC trial asserts Najib had absolute knowledge of RM42m in his accounts The prosecution in Datuk Seri Najib Razak’s SRC International Sdn Bhd trial contended that the former prime minister had absolute knowledge of RM42 million from SRC which ended up in his accounts. Appointed prosecutor Datuk V Sithambaram pointed out an oddity — that when Najib removed Nik Faisal Ariff Kamil as the chief executive officer (CEO) of SRC amid complaints about financial misconduct, he still kept the latter as the mandate holder. 06/03/2020
Najib did not check accounts as late secretary would have confirmed if there were enough funds — defence The defence concluded its submissions on the three money laundering charges faced by Datuk Seri Najib Razak by saying that the former premier did not check the deposits in his accounts as he thought they were Saudi Arabian donations, and that his deceased senior private secretary would have confirmed if there were enough funds or not. Lawyer Harvinderjit Singh took one and a half hours to conclude the submissions before the prosecution, saying his client had a firm belief the money he spent was from donations as the funds had come into his accounts over a period of a few years. 06/03/2020
Najib’s defence urges court to avoid public opinion Although the public may get angry due to the seriousness of the allegations, the facts of the case must prevail by RAHIMI YUNUS/ pic by HUSSEIN SHAHARUDDIN DATUK Seri Mohd Najib Razak’s (picture) defence in the SRC International Sdn Bhd trial urged the High Court to make a decision free from the influence of public opinion. […] 06/03/2020
Defence to wrap up submissions today KUALA LUMPUR (June 3): The third day of submissions for the SRC International Sdn Bhd will see former Prime Minister Datuk Seri Najib Abdul Razak’s defence wrap up and make way for the prosecution. Najib’s lawyers informed Justice Nazlan Mohd Ghazali yesterday that they will use the first part of the morning to complete their submissions before the prosecution led by Appointed prosecutor Datuk V. Sithambaram takes over. 06/03/2020
Athenex, Inc. (NASDAQ:ATNX) Insiders Increased Their Holdings We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are... 06/02/2020
6th Telangana Formation Day: A quick look at the history of India's youngest state Every year on June 2 is observed as Telangana Formation Day as this is the day when the Telangana state was officially formed. The Government of India declared this historic day for the Telangana, the youngest state in India in 2014. Prime Minister Narendra Modi on Tuesday took to Twitter and congratulated Telangana for attaining statehood. 06/02/2020
Bukan Najib, tapi 'pihak ke-3' seleweng dana SRC, kata peguam bela Harvinderjit Singh berkata, bekas CEO SRC International, Nik Faisal Ariff Kamil dan ahli perniagaan, Low Taek Jho yang 'memanipulasi' akaun bank bekas perdana menteri itu. 06/01/2020
The Future Of Payments Beyond The Pandemic \| PYMNTS.com Six panelists across the payments spectrum — from banking to cross border — discuss the shift to digital, and why bitcoin is not the wave of the future. 06/01/2020
Ex-AG agreed to Guan Eng's request to unlock tycoon's money despite only 12% return of 1MDB funds Property boss had his bank accounts unfrozen just two weeks after the former finance minister wrote to Tommy Thomas, exchanges reveal. 06/01/2020
INTERVIEW: Real estate exec Fabrice Susini confident Saudi Arabia’s coronavirus-hit mortgage demand will return What a difference a pandemic makes. At the turn of 2020, Fabrice Susini, CEO of Saudi Real Estate Refinance Company (SRC), could look back on two years of significant progress toward the provision of affordable home ownership for the Kingdom’s aspirational young population. Increased property ownership was one of the main aims of the plan to diversify the Saudi economy away from oil dependency, setting a target of 70 percent home ownership by 2030. 05/30/2020
Reopening Revival? REITs And Homebuilders Add To Rally U.S. equity markets added to their reopening rally this week as states and countries around the world continue to lift lockdowns while new cases of coronavirus 05/30/2020
What led to the DNAA for Riza Aziz It will not have been a walk in the park for the prosecution to prove the money laundering charges against the Hollywood movie producer. 05/30/2020
Athenex Presents Interim Data from Oral Paclitaxel Phase II Study in Cutaneous Angiosarcoma at ASCO20 Virtual Scientific Program BUFFALO, N.Y., May 29, 2020 -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel. 05/29/2020
The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 28) ADC Therapeutics SA (NYSE:... 05/29/2020
Dividend Cuts And Overdue Rent: REIT Earnings Recap Did the rent get paid? Rent collection and dividend cuts were the primary themes of the most newsworthy and consequential REIT earnings season since the Great F 05/28/2020
Edited Transcript of ATNX earnings conference call or presentation 7-May-20 12:00pm GMT Q1 2020 Athenex Inc Earnings Call 05/27/2020
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athenex, Inc. - ATNX Pomerantz LLP is investigating claims on behalf of investors of Athenex, Inc. (“Athenex” or the “Company”) (ATNX). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. The investigation concerns whether Athenex and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 05/27/2020
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athenex, Inc. - ATNX NEW YORK, NY / ACCESSWIRE / May 25, 2020 / Pomerantz LLP is investigating claims on behalf of investors of Athenex, Inc. ("Athenex" or the "Company") (NASDAQ:ATNX). Such investors are ... 05/25/2020
Odisha receives Rs 500-cr interim aid from Centre for restoration work post cyclone rampage After conducting an aerial survey of the cyclone-hi districts of Odisha and holding a review meeting here o Friday, Modi had announced Rs 500 crore advance assistance for the state. 05/24/2020
Odisha receives Rs 500-cr interim aid from Centre for restoration work post-Cyclone Amphan Cyclone-battered Odisha has received Rs 500 crore from the Centre as advance assistance for restoration work, a senior official said. 05/24/2020
The Week Ahead In Biotech: ASCO Presentations In The Spotlight Biotech stocks closed the week ended May 22 higher, with stray clinical readouts and COVID-19 drug- and vaccine-related news moving stocks in the sector. Surface Oncology Inc (... 05/24/2020
Signs Of V-Shaped Housing Recovery U.S. equity markets surged this week, buoyed by positive vaccine data and on renewed hopes of a V-shaped economic recovery as countries around the world begin t 05/23/2020
Odisha Govt Asks Collectors of Cyclone-affected Districts to Submit Initial Report on Damages The direction came after 'Amphan' hit coastal districts like Jagatsinghpur, Kendrapara, Bhadrak and Balasore and parts of the northern district of Mayurbhanj. 05/20/2020
New Movember survey results show more conversations are needed for men who are struggling during COVID-19 LOS ANGELES, May 20, 2020 /PRNewswire via COMTEX/ -- LOS ANGELES, May 20, 2020 /PRNewswire/ -- According to new research, 88% of U.S. men surveyed found it... 05/20/2020
Woman Gives Birth in Fire Service Vehicle as Cyclone Amphan Pummels Odisha Both the mother and the newborn are healthy and have been shifted to Mahakalpada government-run community healthcentre in the district, Deputy Fire Officer PK Dash said. 05/20/2020
Scottish retail sales plummet to lowest level on record - Evening Telegraph Retail sales in Scotland have plummeted to their lowest level since records began. 05/19/2020
Odisha takes on Amphan evacuation with Covid-19 containment The cyclone is expected to make landfall before Wednesday evening, probably somewhere between Digha in West Bengal and Hatiya Islands in Bangladesh, as a ‘Very Severe Cyclonic Storm with wind speeds as strong as 155-165kmph. 05/19/2020
Cyclone ‘Amphan’ moves closer to Odisha coast, rain lashes several In the morning, 'Amphan' lay centred over west-central Bay of Bengal, about 520 km south of Paradip (Odisha), 670 km south-southwest of Digha (West Bengal) and 800 km south-southwest of Khepupara in Bangladesh, said H R Biswas, the director of Meteorological Centre, Bhubaneswar. 05/19/2020
Cyclone Amphan, Weather Forecast Today LIVE Updates: Storm weakens into ‘extremely severe’ category, rain lashes several parts of Odisha Weather Forecast Today, Cyclone Amphan Live News Updates: Cyclone Amphan is likely to weaken into an extremely severe cyclonic storm, move north-northeastwards over the Bay of Bengal and cross West Bengal-Bangladesh coasts between Digha and Hatia Islands during Wednesday afternoon. 05/19/2020
Athenex Announces Participation in the 2020 RBC Capital Markets Global Healthcare Virtual Conference BUFFALO, N.Y., May 19, 2020 -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies. 05/19/2020
Cyclone Situation Under Control So Far in Odisha, Says Special Relief Commissioner He said the district administrations have started the evacuation process from Monday in the coastal districts and the entire evacuation process will be completed by this evening. 05/19/2020
Cyclone Amphan: 6 West Bengal districts including Kolkata, Hooghly, others brace for severe storm Cyclone Amphan has turned into super-storm which is expected to make landfall on Wednesday evening and may impact two coastal region states including West Bengal and Odisha. The Meteorological (MeT) Department has issued an 'orange message' for West Bengal, warned of extensive damage in Kolkata, Hooghly, Howrah, South and North 24 Parganas and East Midnapore districts. 05/19/2020
Bitcoin Revolution Scam Exposed by SEC - InsideBitcoins.com The Securities and Exchange Commission (SEC) of the Philippines has recently warned the public about a well-known bitcoin scam known as Bitcoin Revolution. Its advisory [...] 05/18/2020
Cyclone Amphan, Weather Forecast Today LIVE Updates: PM Modi reviews preparedness; 25 NDRF teams deployed Cyclone Amphan, Weather Forecast Today Live News Updates: The Odisha government is considering evacuation of 11 lakh people in the vulnerable areas. The MeT department has issued an 'orange warning' for West Bengal. 05/18/2020
Coronavirus Roundtable - REITs' Outlook Starting To Clear Up (NYSEARCA:VNQ) While uncertainty seems likely to remain with us for some time, a panel of REIT investors argues that we're turning a corner. With rent collection percentages c 05/18/2020
ALERT: Amphan intensifies into extremely severe cyclonic storm; NDRF on standby Cyclonic storm Amphan, that has been brewing in the Bay of Bengal has intensified further into an extremely severe cyclonic storm and is likely to become Super Cyclone, India's Met Department (IMD) has warned. The cyclonic storm Amphan is likely to hit the coastal districts of West Bengal, Odisha and many parts of Bangladesh. 05/18/2020
Odisha, WB brace to fight cyclone 'Amphan' amid Covid -19 crisis; NDRF deployed The cyclone is likely to make a landfall somewhere between Digha in West Bengal and Hatiya Islands in Bangladesh on Wednesday 05/17/2020
Cyclone Amphan: Odisha, West Bengal brace to fight cyclonic storm amid Covid-19 crisis; NDRF deployed In Odisha, 10 teams have been deployed in seven districts -- Puri, Jagatsinghpur, Kendrapara, Jajpur, Bhadrak, Balasore and Mayurbhanj. One team of NDRF consists of around 45 personnel. 05/17/2020
SRC maintains ban on sporting activities - NewZimbabwe.com Spread This NewsBy Sports Reporter ZIMBABWE’S sports regulatory body, the Sports and Recreation Commission insists that all sporting activities remain banned in the country due to the coronavirus despite conflicting statements from the body and the Ministry of Youth, Sport, Arts and Recreation on Thursday. The Sports Ministry appeared to suggest that it had given 05/17/2020
Odisha urges Centre to temporarily suspend Shramik trains due to cyclone Apart from Shramik Special trains, the Indian Railways has also started operating special passenger trains between New Delhi and Bhubaneswar 05/16/2020
Odisha urges Centre to temporarily suspend ‘Shramik Special’ trains due to impending cyclone Thanking the Centre for running special trains to ferry stranded migrant workers, Jena said the impending situation could create problems in receiving the passengers and taking them to quarantine centres as per the Covid-19 guidelines. 05/16/2020
Low pressure over Bay of Bengal intensifies into depression: MeT The well-marked low pressure area over southeast Bay of Bengal intensified into a depression on Saturday morning, laying centred around 1,100 km south of Paradip in Odisha, the MeT department said. The system, which is around 1,250 km south of Digha 05/16/2020
8 Overlooked REITs Beating The Crisis We search for REITs with dislocations between price and fundamentals. These particular REITs are resilient through this environment making the cheap prices oppo 05/13/2020
Visa Expands Visa Token Service \| PYMNTS.com Visa said Wednesday that 28 new partners — spanning a range of gateway acquirers and technology partners — are joining Visa Token Service. 05/13/2020

Unlock

ATNX Ratings Summary

ATNX Quant Ranking